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Abstract		
Low	back	 pain	 (LBP)	 affects	 up	 to	 80%	of	 the	 global	 population	 at	 some	point	 during	
their	 life.	The	costs	associated	with	LBP	are	estimated	at	$100	billion	per	year,	putting	
significant	 strains	 on	 our	 healthcare	 system.	 As	 intervertebral	 disc	 (IVD)	 herniation	 is	
one	 of	 the	 major	 causes	 of	 LBP	 we	 decided	 to	 focus	 on	 herniation	 facilitated	
inflammatory	 responses,	 where	 damage	 caused	 by	 herniation	 triggers	 an	 innate	
immune	 response	 which	 likely	 results	 in	 pain,	 inflammation,	 and	 recruitment	 of	
specialized	innate	immune	cells	like	macrophages	to	the	affected	area.	Since	the	role	of	
the	 inflammatory	 response	 is	 relatively	 uncharacterized	 in	 the	 IVD,	 the	 goals	 of	 this	
research	were	to	1)	characterize	this	early	innate	immune	response	by	isolating	annulus	
fibrosus	 (AF)	 and	 nucleus	 pulposus	 (NP)	 cells	 from	 rat-tail	 IVDs	 and	 growing	 them	 in	
culture,	2)	determine	 the	pattern	 recognition	 receptors	 (PRR)	 repertoire	of	 these	cells	
used	 to	 initiate	 inflammation	 and	 3)	 identify	 their	 ability	 to	 mount	 an	 inflammatory	
response	 following	 an	 appropriate	 damage	 associated	 molecular	 pattern	 (DAMP)	
stimulus.	Furthermore	we	determined	the	effects	of	this	inflammatory	response	at	the	
tissue	level	on	the	biomechanical	properties	of	functional	spine	units	collected	from	rat-
tails.	 During	 the	 course	 of	 this	 experiment	 we	 discovered	 that	 changes	 in	 cytokine	
production	 at	 the	 cellular	 level	 as	 a	 result	 of	 DAMP	 stimulation	 and	 the	 resulting	
inflammatory	 response	 had	 tangible	 consequences	 to	 IVD	 biomechanics	 at	 the	 tissue	
level.	Injecting	discs	with	5.0	μg/mL	of	decorin,	while	showing	no	effects	24	hours	post	
injection,	 resulted	 in	 significant	 increases	 in	 IVD	 compliance	 6	 days	 post	 injection	
(p=0.016)	 compared	 to	 PBS	 injected	 controls.	 Increased	 laxity	 as	 a	 result	 of	 DAMP	
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mediated	 inflammation	supports	our	hypothesis	of	 IVD	degeneration	as	a	condition	of	
the	 inflammatory	 response.	 This	 will	 open	 new	 avenues	 exploring	 the	 possibility	 of	
novel	 therapeutics	 targeting	 upstream	 PPRs	 stopping	 inflammation	 before	 the	
degenerative	cascade	takes	effect.																																				
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Chapter	1.	Introduction	and	Literature	Review		 Low	back	pain	(LBP)	affects	1	in	5	people	at	any	given	time,	with	over	85%	of	the	population	experiencing	some	sort	of	lower	back	pain	in	their	lifetime	(Andersson,	1998;	Walker,	2000).	Injury	due	to	LBP	may	lead	to	high	medical	costs	for	treatment,	and	lost	income	and	productivity	when	disability	leave	is	required.	The	costs	associated	with	LBP	are	estimated	to	be	approximately	$100	billion	/	year	in	the	US	alone	(Katz,	2006).	A	major	cause	of	LBP	is	mechanical	compression	of	the	nerve	root	during	injury,	however	the	role	of	the	innate	immune	response	and	how	it	causes	low	back	pain	has	not	been	fully	investigated	(Al-Obaidi	&	Mahmoud,	2014;	Atlas	&	Deyo,	2001;	Splittstoesser	et	al.,	2012).	Therefore	this	thesis	aimed	to	determine	exactly	what	components	of	the	innate	immune	response	occur	following	IVD	herniation.	This	will	allow	us	to	better	understand	the	causes	of	LBP	so	more	effective	treatments	can	be	developed.		
1.1 	Prevalence	of	Low	Back	Pain		 Recent	 reports	 suggest	 that	 almost	 20%	 of	 patients	 experiencing	 LBP	develop	chronic	conditions	lasting	3	or	more	months	and	40%	of	patients	reporting	lifelong	incidence	of	reoccurring	episodes	(Hoy	et	al.,	2012).	Injury	due	to	LBP	has	been	 shown	 to	 cause	 significant	 economical	 impacts	not	only	due	 to	high	medical	costs	for	treatment,	but	also	diversion	of	medical	resources,	physicians	time,	and	the	lost	 income	when	disability	 leave	 is	 required.	The	 total	 costs	 associated	with	LBP	are	estimated	 to	be	approximately	$100	billion/year	 in	 the	US	alone	(Katz,	2006).	Despite	these	costs,	LBP	still	has	relatively	few	treatment	options	available	with	the	
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majority	 of	 cases	 healing	 themselves	 with	 rest	 and	 time.	 Notwithstanding,	 LBP	related	 injuries	 are	 the	 second	 leading	 cause	 of	 physician	 visits	 and	 third	 major	reason	for	surgical	intervention	(Andersson,	1998).			
1.2 	Causes	of	Low	Back	Pain		Despite	 LBP	 prevalence	 and	 its	 symptoms	 reaching	 every	 demographic	 –	crossing	age,	gender,	and	racial	groups,	little	consensus	has	been	reached	regarding	the	 origin	 of	 LBP.	 Instead,	 symptoms	 have	 been	 noted	 to	 stem	 from	 a	 number	 of	triggering	factors,	which	can	be	roughly	broken	down	into	three	main	groups.	These	include	biological	sources,	such	as	nutrition,	aging,	and	genetics	(Adams	&	Roughley,	2006a;	 Kadow	 et	 al.,	 2015);	 anatomical	 sources,	 including	 nerve	 roots,	 muscle,	bones	and	joints,	organs	within	the	abdominal	cavity,	and	IVDs	themselves	(Allegri	et	al.,	2016);	and	 finally	neuropathic	causes	which	are	 influenced	by	psychological	factors	such	as	stress,	anxiety,	or	depression	(Besen	et	al.,	2015;	Deyo	et	al.,	2015).		Adding	 to	 the	 complication	of	diagnosing	LBP	 is	 that	magnetic	 resonance	 imaging	(MRI)	of	both	 symptomatic	 and	asymptomatic	patients	 are	only	weakly	 related	at	best	 to	 described	 symptoms	 (Allegri	 et	 al.,	 2016).	 Furthermore	 cross-sectional	studies	 have	 found	 that	 36%	 of	 asymptomatic	 patients	 over	 the	 age	 of	 60	 had	herniated	 IVDs,	 21%	 had	 spinal	 stenosis,	 and	 more	 than	 90%	 had	 bulging	 or	degenerated	IVDs	(Boden	et	al.,	1990).	Due	to	the	high	prevalence	of	IVD	herniation	and	 its	 ability	 to	 accelerate	 the	 degeneration	 of	 the	 IVD	 following	 injury,	 further	study	into	this	area	is	needed	(Fardon	et	al.,	2014).		In	addition	to	the	causes	previously	listed,	degeneration	of	the	IVD	is	one	of	the	major	contributors	to	LBP.	However	it	is	still	unknown	why	some	degeneration	
Matthew	Guerreiro	2018©	 12	
cases	 remain	 asymptomatic	 whilst	 others	 lead	 to	 pain.	 Furthermore	 not	 only	 is	degeneration	a	natural	occurrence	developing	with	age	but	also	a	symptom	of	injury	to	 the	 IVD.	Unsurprisingly,	81.1%	of	patients	 in	one	 study	who	 reported	LBP	also	had	associated	IVD	degeneration	(Luoma	et	al.,	2000).		
1.3 	Anatomy	of	the	IVD		 The	human	IVD	can	be	broken	down	into	four	general	regions;	the	AF	forms	the	outer	layer	of	the	IVD	and	can	be	further	subdivided	into	the	outer	AF	and	the	inner	 AF	 which	 forms	 the	 transition	 zone	 between	 the	 AF	 and	 NP	 regions,	 the	gelatinous	 NP	 at	 the	 center	 of	 the	 IVD,	 and	 finally	 the	 vertebral	 end	 plates	separating	 the	 IVD	 from	 the	 vertebral	 body	 (Figure	 1;	 Tomaszewski	 et	 al.,	 2015).		With	an	average	cross	sectional	area	of	1727	mm2	and	IVD	height	of	9.93	mm,	the	IVD	 accounts	 for	 approximately	 30%	 of	 the	 total	 length	 of	 the	 spinal	 column	(O’Connell	et	al.,	2007;	Urban	&	Roberts,	2003).		As	the	IVD’s	primary	function	is	to	distribute	forces	and	transfer	loads	across	the	spine	it	relies	on	each	region	having	a	unique	 cellular	makeup,	 and	 distinct	morphological	 and	mechanical	 properties	 to	handle	 the	 complex,	 multidirectional	 mechanical	 forces	 to	 which	 the	 spine	 is	regularly	 exposed.	 In	 addition	 to	 this	 the	 IVD	 is	 both	 aneural	 and	 avascular.	 This	makes	movement	of	cellular	resources	and	signals	across	the	IVD	more	difficult	and	relies	heavily	on	the	diffusion	of	molecules	through	the	AF	and	vertebral	endplates	from	neighboring	vessels.		
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Figure	1:	Structure	and	Function	of	the	IVD	A	diagram	depicting	the	different	regions	of	the	IVD,	The	NP,	primarily	composed	of	a	 highly	 hydrated	 gel	 made	 of	 proteoglycan	 and	 hyaluronan	 long	 chains	 with	randomly	organized	type	II	collagen	fibres	and	radially	organized	elastin	 fibres.	 In	contrast	 the	 AF	 is	 comprised	 of	mostly	 type	 I	 collagen	 fibres	 in	 the	 outer	 region	transitioning	 to	 type	 II	 collagen	 fibres	 in	 the	 inner	 region.	 The	 AF	 is	 comprised	angled	lamellar	rings	lying	parallel	with	each	other.		(Tomaszewski	et	al.,	2015)																					
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1.4.1	The	Nucleus	Pulposus		 The	NP	is	primarily	composed	of	a	highly	hydrated	gel	made	of	proteoglycans	and	 hyaluronan	 long	 chains.	 Whilst	 proteoglycan	 concentration	 varies	 between	species,	 the	mammalian	NP	 typically	 expresses	 approximately	90%	aggrecan	with	lesser	 quantities	 of	 decorin,	 versican,	 and	 other	 proteoglycans	 (Colombier	 et	 al.,	2014).	The	hyaluronan	long	chains	carry	a	negative	charge	responsible	for	creating	osmotic	 gradients,	 drawing	 water	 into	 the	 IVD	 and	 maintaining	 the	 hydrostatic	pressure	within	the	IVD.	It	is	this	osmotic	gradient	which	allows	the	IVD	to	standup	to	 extreme	 repetitive	 stresses	 placed	 on	 the	 spine.	 Allowing	 the	 IVD	 to	 evenly	distribute	mechanical	forces	across	the	entire	surface	area	of	the	IVD	facilitates	this	phenomenon.	Embedded	within	the	gelatinous	matrix	are	randomly	organized	type	II	 collagen	 fibers	 and	 radially	 organized	 elastin	 fibers	which	 further	 contribute	 to	the	IVD’s	elasticity	and	its	ability	to	dissipate	loads	(Figure	1)	(Adams	&	Roughley,	2006a;	 Hickey	 &	 Hukins,	 1980;	 Tomaszewski	 et	 al.,	 2015).	 Cells	 in	 the	 NP	 are	considered	to	be	highly	specialized	due	to	the	avascular	nature	of	the	IVD	leading	to	a	 hypoxic	 environment	 of	 approximately	 1%	 O2	 within	 the	 NP	 region	 of	 the	 IVD	(Risbud	et	al.,	2010).	The	NP	cells	are	known	to	have	a	heterogeneous	morphology	with	 the	 majority	 of	 cells	 taking	 on	 a	 notochordal-like	 morphology	 in	 mammals,	however	this	morphology	general	changes	to	a	more	chondrocyte	like	morphology	by	approximately	3	month	in	humans.	
1.4.2	The	Outer	Annulus	Fibrosus		 The	 outer	 AF	 is	 comprised	 of	 15	 -20	 lamellae	 or	 layers	 of	 tissue	 arranged	similarly	 to	 tree	 rings.	 	Primarily	made	of	 type	 I	 collagen	 fibers	 (and	some	 type	 II	
Matthew	Guerreiro	2018©	 15	
collagen	 fibers),	 the	 fibers	 are	 highly	 organized	 lying	 parallel	 with	 each	 other	 to	maximize	strength.	The	orientation	of	the	collagen	fibers	alternate	in	direction	with	each	 successive	 lamellar	 layer	 (Pezowicz	 et	 al.,	 2005).	 In	 addition	 to	 the	 large	proportion	of	collagen	fibers,	some	elastin	fibers	and	proteoglycans,	such	as	decorin,	are	 also	 found	 in	 the	 AF	 region	 of	 the	 IVD	 though	 not	 nearly	 in	 as	 high	concentrations	as	the	NP.	The	AF’s	ability	to	attract	water	and	maintain	hydrostatic	pressure	via	the	release	of	proteoglycans	in	the	AF	ECM	are	necessary	to	opposing	compressive	forces	on	the	IVD	just	as	previously	described	in	the	NP.		
1.4.3	The	Inner	Annulus	Fibrosus		 The	inner	AF	expresses	a	mixture	of	characteristics	seen	in	the	outer	AF	and	NP	regions	of	the	IVD	hence	why	it	is	commonly	referred	to	the	transitional	region	between	 the	 AF	 and	 NP.	 As	 with	 the	 outer	 AF	 the	 cells	 of	 the	 inner	 AF	 are	fibroblastic	 in	nature	 though	 they	exhibit	a	 rounded	chondrocyte	 like	morphology	analogous	with	cells	of	the	NP.		Lamellar	 structural	 integrity	 is	maintained	by	 a	 highly	 complex	 interaction	between	 both	 inter-lamellar	 and	 intra-lamellar	 matrices.	 Connective	 tissue	 found	within	 each	 lamellae	 helps	maintain	 adhesion	between	 adjacent	 collagen	bundles.	Connective	 tissues	 between	 the	 individual	 lamellae	 known	 as	 intra-lamellar	matrices	 help	 prevent	 delamination	 or	 separation	 of	 the	 lamellae.	 This	 not	 only	gives	 this	 region	 of	 the	 IVD	 its	 highly	 dense	 and	 fibrous	 properties,	 but	 also	 its	strength,	 allowing	 it	 to	withstand	 repeated	 compressive	 forces	 from	daily	 activity	(Figure	1)	(Hickey	&	Hukins,	1980;	Le	Maitre	et	al.,	2004;	Tomaszewski	et	al.,	2015;	Zhao	et	al.,	2007;	Urban	&	Roberts,	2003).		
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Cells	of	the	AF	maintain	a	fibroblastic-like	morphology	throughout	life	invivo	as	well	as	in	culture.	This	is	in	contrast	to	NP	cells,	which	are	known	to	change	their	morphology	 from	 notochordal	 like	 cells,	 stemming	 from	 their	 notochordal	embryonic	origins,	 to	 a	 rounded	 chondrocyte	 like	morphology	 at	 approximately	3	months	 of	 age.	 In	 culture	 the	NP	 cells	 are	 seen	 to	 change	 their	morphology	 from	round	notochord	like	cells	to	elongate	spindle	shaped	cells	(Chen	et	al.,	2013)	
1.4.4	The	Vertebral	End	Plate		 Each	 IVD	 is	 sandwiched	 between	 plates	 of	 hyaline	 cartilage-providing	 a	barrier	between	 the	 IVD	and	 the	end	of	 the	adjacent	vertebrae.	This	 region	of	 the	IVD	shows	similar	characteristics	to	the	rest	of	the	IVD,	such	as	being	both	avascular	and	aneural,	as	well	as	being	able	to	assist	in	distributing	forces	across	the	IVD	and	maintaining	the	pressure	of	the	NP	(Raj,	2008;	Lotz	et	al.,	2013).	The	vertebral	end	plate	 is	 relatively	 thin	 compared	 to	 other	 IVD	 regions	 thus	 allowing	 diffusion	 of	nutrients,	 small	 molecules,	 and	 waste	 between	 the	 avascular	 IVD	 and	 the	vascularized	vertebral	bodies	(Lotz	et	al.,	2013).	However	the	region	also	serves	as	an	important	barrier	from	surrounding	tissue	and	blood	vessels,	helping	to	maintain	the	immunoprivileged	properties	of	the	IVD.	During	an	innate	immune	response	the	VEP	would	 not	 only	 aid	 in	 the	 promoting	 the	 inflammatory	 process	 by	 producing	cytokines	of	its	own,	it	would	also	facilitate	IVD	repair	by	allowing	nutrients	to	cross	into	the	IVD	from	the	nearby	vascularized	bone	(Lotz	et	al.,	2013).		Whilst	 the	 NP,	 inner	 AF,	 and	 outer	 AF	 are	 considered	 to	 be	 significantly	differentiated	 and	 thus	 distinguishable	 in	 healthy	 adult	 IVDs,	 a	 consequence	 of	
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ageing	and	natural	IVD	degeneration	is	the	blurring	of	boundaries	between	the	AF	and	NP	along	with	the	loss	of	proteoglycans	and	type	I	collagen	the	IVD	also	begins	to	 lose	 its	 strength	 and	 ability	 to	 distribute	 forces	 increasing	 the	 probability	 of	injuries	like	herniation.		
1.4 	Injury	to	the	IVD		 IVD	 injury	 is	 a	 multifaceted	 issue	 with	 injury	 to	 the	 IVD	 presenting	 as	 two	primary	 forms,	 the	 first	 is	 age-related	 injury	 stemming	 from	 the	 natural	degeneration	the	IVD	undergoes	over	time.	The	second	comes	from	physical	injury	to	 the	 IVD	with	 the	most	 prevalent	 type	 of	 injury	 being	 herniation.	 In	 either	 case	injury,	whether	degenerative	or	physical,	can	lead	to	altered	loading	and	dispersion	of	forces	across	the	IVD	(Iatridis	et	al.,	2009).	This	can	prevent	healing	in	the	IVD	by	aggravating	 inflammation,	 but	 can	 also	 lead	 to	 damage	 of	 other	 IVDs	 particularly	when	abnormal	loading	of	involved.	Overall	IVD	injury	is	considered	to	be	a	result	of	multiple	 factors,	 any	of	which	 can	predispose	or	hasten	 the	 chances	 an	 individual	experiences	IVD	damage.	Unsurprisingly,	the	constant	stresses	placed	on	the	spine	in	 conjunction	 with	 lifestyles	 promoting;	 poor	 spine	 posture,	 increased	 obesity	rates,	 and	 poor	 nutrition	 all	 increase	 risk	 of	 IVD	 injury.	 Similarly,	 workplaces	demanding	 ever	 increasing	 levels	 of	 productivity,	 higher	 physical	 demands	 in	 the	way	of	increasing	load,	repetitive	movements,	and	abnormal	loading	patterns,	have	all	 been	 listed	 as	 possible	 causes	 raising	 the	 number	 of	 low	 back	 related	 injuries	seen	each	year	 (Adams	&	Roughley,	 2006b;	Chan	et	 al.,	 2006;	Kadow	et	 al.,	 2015;	Zhao	et	al.,	2007;	Urban	&	Roberts,	2003).	In	addition	to	the	plethora	of	factors	that	
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lead	to	injury,	the	IVD’s	avascular	nature	means	that	repair	to	the	IVD	is	limited	by	nutrients	 available	 and	 how	 quickly	 they	 can	 be	 replaced	 via	 diffusion	 from	 the	surrounding	tissue	and	blood	vessels.		
1.5.1	Herniation		 Herniation	of	the	IVD	is	defined	as	when	the	inner	NP	migrates	through	the	AF	 layer	and	 is	often	 characterized	based	on	 severity	 (Adams	&	Roughley,	2006a;	Gregory	&	Callaghan,	2011).	The	first	stage	of	herniation,	called	protrusion,	involves	the	 partial	 migration	 of	 the	 NP	 layer	 into	 the	 AF.	 The	 second	 stage,	 extrusion,	 is	characterized	when	the	NP	completely	migrates	though	the	AF	and	is	visible	on	the	exterior	of	 the	IVD.	The	third	stage,	sequestration,	 is	when	herniated	material	(NP	and/or	AF)	detaches	from	the	IVD	and	becomes	free	floating	(Figure	2)	(Gregory	&	Callaghan,	2011;	Guerin,	2006).	Depending	on	 the	 severity	of	 the	herniation,	 IVDs	may	only	be	subject	to	protrusion	of	the	NP	into	the	AF,	or	may	experience	multiple	stages	of	herniation	as	the	complexity	and	severity	of	the	case	increases.	IVDs	that	have	 advanced	 degeneration	 are	 less	 prone	 to	 this	 sort	 of	 injury	 as	 they	 lack	 the	ability	 to	 maintain	 sufficient	 hydrostatic	 pressure	 to	 force	 the	 NP	 into	 the	 AF	(Schmidt	et	al.,	2007).		
1.4.1	IVD	Degeneration			 Due	to	the	prevalence	of	IVD	injury	it	is	difficult	to	determine	if	degeneration	originates	 from	 injury,	 for	example	 IVD	herniation,	or	 if	 it	 is	primarily	age	related	(Adams	&	Roughley,	2006b;	Zhao	et	 al.,	 2007).	 In	most	 cases,	degeneration	of	 the	IVD	leads	to	a	reduction	in	the	IVD’s	ability	to	distribute	forces.	This	can	be	due	to	
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loss	 of	 proteoglycans	 in	 the	 NP,	 changes	 to	 ECM	 morphology,	 failure	 to	 repair	damaged	 IVD	 ECM,	 or	 improper	 IVD	 loading	 due	 to	 other	 age-related	symptoms(Adams	&	Roughley,	2006b).	Degeneration	compromises	the	IVD’s	ability	to	 distribute	 mechanical	 loads,	 which	 can	 put	 increased	 strain	 on	 the	 IVD	 and	exacerbate	inflammation	within	the	IVD	(Zhao	et	al.,	2007).									 	
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Figure	2:	Stages	of	Intervertebral	Disc	Herniation	The	first	stage	of	herniation,	called	prolapse,	involves	the	partial	migration	of	the	NP	layer	into	the	AF.	The	second	stage,	extrusion,	is	characterized	when	the	NP	completely	migrates	 though	 the	 AF	 and	 is	 visible	 on	 the	 exterior	 of	 the	 IVD.	 The	third	stage,	sequestration,	is	when	herniated	NP	material	detaches	from	the	IVD	and	becomes	free	floating	(Dawson	&	An,	2016).					
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1.6.	The	Innate	Immune	Response		The	 innate	 immune	 system	 is	 the	 body’s	 first	 line	 of	 defense	 against	 infection.	 It	consists	 of	 constitutive	 immunity	 and	 induced	 immunity.	 Constitutive	 immunity	includes	 natural	 barriers	 like	 the	 skin,	 whilst	 induced	 immunity	 uses	 pattern	recognition	receptors	(PRRs)	to	detect	damage	associated	and	pathogen	associated	molecular	 patterns	 (DAMPs	 and	 PAMPs)	 and	 initiate	 appropriate	 immune	responses.	Due	to	the	lack	of	vascularization	of	the	IVD	and	thus	the	lack	of	access,	particularly	 to	 the	 inner	 NP	 layer,	 the	 IVD	 is	 considered	 to	 be	 one	 of	 the	 body’s	major	immunoprivileged	sites;	essentially	excluding	the	adaptive	immune	response	from	 the	 IVD	 (Clouet	 et	 al.,	 2009;	 Hoy	 et	 al.,	 2012).	 Exclusion	 of	 the	 adaptive	immune	 response	 forces	 the	 tissue	 to	 rely	 on	 innate	 immunity	 to	 respond	 to	damage.	 Though	 it	 is	 not	 understood	 exactly	 how	 this	 innate	 immune	 response	progresses,	 production	 of	 pro-inflammatory	 cytokines	 following	 IVD	 damage	 has	been	 well-documented	 and	 is	 believed	 to	 cause	 further	 IVD	 degeneration	(Colombini	 et	 al.,	 2008;	 Smith	 et	 al.,	 2011;	Walker	&	Anderson,	 2004;	 Zhao	 et	 al.,	2007).			
1.6.1	Pattern	Recognition	Receptors		 PRRs	 are	 proteins	 expressed	 by	 every	 cell	 and	 facilitate	 both	 intracellular	communication	as	well	 as	 cell-to-cell	 communication	 (Kawai	&	Akira,	 2010).	Each	cell	type	expresses	a	different	repertoire	of	PRRs	dictating	the	scope	of	their	ability	to	 detect	 different	 molecules.	 The	 molecules	 detected	 by	 PRRs	 can	 be	 generally	broken	down	 into	 two	main	categories:	PAMPs,	which	are	 foreign	elements	 to	 the	
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host	 such	as	bacterial	 cell	wall	 components	 like	 lipopolysaccharide	 (LPS;	Kawai	&	Akira,	 2010)),	 and	 host-derived	 molecular	 patterns	 linked	 to	 cell	 damage/death,	also	 known	 as	 DAMPs	 (Babelova	 et	 al.,	 2009;	 Pétrilli	 et	 al.,	 2007).	 These	 include	degraded	 ECM,	 uric	 acid,	 extracellular	 DNA	 or	 RNA,	 extracellular	 ATP,	 amongst	other	 compounds	 (Pétrilli	 et	 al.,	 2007).	 As	 each	 cell	 type	 expresses	 a	 different	collection	of	PRRs	and	the	exact	PRR	expression	profile	of	AF	and	NP	cells	has	never	been	fully	characterized,	we	did	not	know	which	DAMPs	AF	and	NP	cells	were	able	to	 identify	 during	 a	 tissue	 damage	 event	 such	 as	 herniation.	 The	 PRR	 whose	expression	was	measured	 in	 the	 AF	 and	NP	 cells	 of	 this	 study	 include:	 TLR	 1-10,	RIG-I,	MDA-5,	NLRP-3,	DAI,	AIM2,	Mincle	and	Dectin.	
1.6.2	Mechanism	of	Inflammation		 Some	TLRs,	such	as	TLR	2	and	4,	are	located	on	the	surface	of	the	cell	and	can	detect	short	 leucine	rich	proteoglycans	or	SLRPs,	which	can	act	as	a	DAMP	during	IVD	 herniation	 (Moreth	 et	 al.,	 2012).	 Binding	 a	 DAMP	 to	 its	 corresponding	 PRR	induces	 a	 signal	 cascade.	 For	 example,	 activation	 of	 TLR2/4	 activates	 a	 signaling	cascade	via	the	adapter	molecule	myeloid	differentiation	factor	88	(MyD88).	MyD88	will	 trigger	 a	 kinase	 dependent	 signaling	 cascade	 through	 the	 cell	 resulting	 in	activation	 of	 the	 transcription	 factors,	 NF-κB	 and	 AP-1,	 protein	 complexes	 that	control	 DNA	 transcription	 and	 cytokine	 production	 (Nilsen	 et	 al.,	 2015).	 Pro-inflammatory	 cytokines	 like	 IL-1,	 IL-4,	 IL-6,	 IL-8	 and	 TNF-α	 expression	 will	 be	regulated	 by	 these	 transcription	 factors.	 Similarly,	 chemokines,	 cytokines	 which	induce	chemotaxis	and	attract	specialized	 immune	cell	 to	 the	site	of	 infection,	 like	macrophage	 inflammatory	 protein	 2	 (MIP2),	monocyte	 chemoattractant	 protein	 1	
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(MCP1),	 and	 regulated	 on	 activation,	 normal	 T	 cell	 expressed	 and	 secreted	(RANTES)	are	also	regulated	by	the	transcription	 factors	NF-κB	and	AP-1.	As	such	cytokines	 are	 immensely	 diverse	 in	 their	 function	 and	 are	 capable	 of	 eliciting	 a	many	responses,	 including	 the	 recruitment	of	numerous	specialized	 immune	cells,	such	as	 leukocytes	by	MIP-2(Yan	et	al.,	1998),	monocytes	by	MCP-1	(Deshmane	et	al.,	2009),	and	T	cells,	eosinophils	and	basophils	by	RANTES	(Crawford	et	al.,	2011;	Sofie	et	al.,	2001).	Furthermore,	IL-6	is	known	to	play	a	role	in	fever	induction	and	MMP	 regulation	 linked	 to	 IVD	degeneration	 (Deng	 et	 al.,	 2016),	whilst	 TNF-α	 is	 a	potent	 immunomodulator	 with	 roles	 in	 vasodilation	 and	 cell	 apoptosis	 (Pfeffer,	2003).														
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Figure	3:	The	innate	immune	response	leading	to	inflammation.	The	innate	immune	response	involves	PRRs	detecting	either	intracellular	or	extracellular	PAMPs	or	DAMPs.		For	example,	surface	PRRs,	such	as	toll-like	receptors	2,	and	4	senses	DAMPs	such	as	liberated	SLRPs	in	the	extracellular	space.	Binding	a	DAMP	to	its	corresponding	PRR	induces	a	signalling	cascade	via	the	adapter	molecule	MyD88.	This	will	trigger	the	kinase	ERK,	which	will	phosphorylate	and	activate	the	transcription	factors	NF-κB	and	AP-1.	These	transcription	factors	increase	pro-inflammatory	cytokines	production	including	IL-6,	MCP-1,	MIP-2,	RANTES,	and	TNF-α.	TNF-α	is	considered	to	be	a	master	inflammatory	regulator	whilst	IL-6	has	been	shown	to	increase	MMP	production.	MIP-2,	RANTES,	and	MCP-2	are	all	involved	in	chemotaxis	and	the	recruitment	of	specialized	innate	immune	cells.	
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1.6.4	TLR	2	and	4	ligands	LPS	(PAMP)	and	Decorin	(DAMP)		Lipopolysaccharide	(LPS)	is	the	PAMP	used	in	the	present	study.	It	is	an	endotoxin	commonly	found	as	a	component	of	the	cell	wall	of	gram-negative	bacteria.	LPS	is	a	large	 molecule	 consisting	 of	 a	 lipid	 A	 domain,	 core	 oligosaccharide,	 and	 an	 O-antigen.	 LPS	makes	 up	 an	 important	 component	 of	 the	 outer	membrane	 of	 gram-negative	bacteria	used	to	protect	the	membrane	integrity	from	chemical	influences	and	help	to	stabilize	the	overall	membrane	structure	(Zhang	et	al.,	2013).	The	lipid	A	component	of	LPS	consists	of	a	phosphorylated	glucosamine	disaccharide	molecule	with	multiple	fatty	acids	attached	to	it.	It	is	with	these	hydrophobic	fatty	acids	that	the	 LPS	 molecules	 stays	 anchored	 to	 the	 surface	 membrane	 of	 bacterial	 cells.	Invading	 bacterial	 cells	 lysed	 by	 the	 host	 immune	 system	 causing	 the	 cells	 wall	fragments	 to	 be	 released	 into	 the	 body.	 Unfortunately	 the	 lipid	 A	 motif	 is	 also	responsible	 for	 the	majority	of	LPS’s	 toxicity,	causing	 fever,	diarrhea,	and	possibly	fatal	 endotoxic	 shock	 commonly	 known	 as	 septic	 shock	 or	 toxic	 shock	 syndrome	(Tzeng	et	al.,	2002).	The	next	major	component	of	LPS	is	the	O-antigen	made	up	of	a	repetitive	glycan	polymer.	It	is	the	outermost	component	of	the	LPS	molecule	and	is	highly	 variable	 between	 bacterial	 strains	 with	 numerous	 structures	 and	configurations	(Raetz	&	Whitfield,	2002).	Configuration	of	the	O-antigen	structures	determines	its	ability	to	protect	the	bacterial	cell	from	antibiotics.	Long	unbranched	molecules	 protect	 the	 cell	 better	 than	 cells	 expressing	 short	 or	 reduced	 o-antigen	molecules	(Rittig	et	al.,	2003;	Tsujimoto	et	al.,	1999).	Conversely	full-length	O-chains	increase	surface	exposure	making	it	a	good	target	for	antibody	recognition.	The	O-
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antigen	 and	 Lipid	 A	 molecules	 are	 covalently	 bound	 to	 a	 core	 domain	 which	contains	 an	 oligosaccharide	 component	 that	 facilitates	 binding	 to	 the	 lipid	 A	complex.	The	core	domain	usually	includes	sugars	and	keto-deoxylctulosonate	along	with	non-carbohydrate	components	like	phosphates	and	amino	acids	(Hershberger	&	 Binkley,	 1968).	 In	 addition	 to	 being	 sensed	 by	 TLR	 4	 and	 trigger	 an	 innate	immune	response	causing	 the	production	of	 inflammatory	chemokines,	 it	 is	also	a	natural	pyrogen	inducing	fever	in	patients	(Duff	&	Atkins,	1982).		 Decorin	is	the	DAMP	used	in	the	present	study.	It	is	a	natural	component	of	the	 IVD	 extracellular	 matrix.	 In	 its	 bound	 form	 it	 has	 no	 apparent	 effects	 on	 the	immune	system	but	once	solubilized	can	act	as	a	DAMP	signaling	a	damage	event	to	the	host	cells	via	the	PRRs,	TLR	2/4	(Schaefer	et	al.,	2005a).	Averaging	between	90	and	140	kDa,	 it	 is	 a	member	of	 the	 short	 leucine	 rich	proteoglycan	 (SLRP)	 family.	Decorin	and	 it	 structurally	similar	cousin,	biglycan,	both	are	made	up	of	a	protein	core	containing	leucine	repeats	and	a	glycosaminoglycan	(GAG)	chain	(Babelova	et	al.,	2009;	Gerard	et	al.,	2003;	Moreth	et	al.,	2012).	Decorin	not	only	 functions	as	a	DAMP	when	solubilized,	but	have	been	found	to	have	far	reaching	roles	linking	the	innate	 and	 adaptive	 immune	 systems	 along	 with	 functions	 in	 microbial	 defense,	tumor	 suppression,	 muscle	 hypertrophy,	 scar	 suppression	 and	 reduction	 and	fibrillogenesis	of	collagen	(Buraschi	et	al.,	2013;	Jumper	et	al.,	2015;	Kanzleiter	et	al.,	2014;	Moreth	 et	 al.,	 2012).	 Release	 of	 decorin	 can	 be	 facilitated	 through	 physical	damage	 to	 the	 IVD	 but	 also	 a	 number	 of	 proteolytic	 enzymes	 such	 as	 bone	morphogenic	 protein	 (BMP)–1,	 matrix	 metalloproteinase	 (MMP)–1,	 MMP-3,	 and	
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MMP-13,	all	of	which	can	cleave	the	protein	core	solubilizing	the	decorin	molecule	(Moreth	et	al.,	2012).		
1.6.5	Effects	of	Inflammation	on	IVD	Biology		While	 it	 is	 widely	 accepted	 that	 damage	 to	 the	 IVD	 induces	 an	 inflammatory	response;	the	exact	progression	of	the	response	and	its	various	effects	in	the	IVD	are	not	well	understood.	On	one	hand,	 it	has	been	well	documented	that	inflammation	contributes	 to	 the	 regeneration	 of	 the	 damaged	 IVD.	 This	 is	 facilitated	 by	 various	cytokines	which	upregulate	cellular	activity,	promote	cell	proliferation	and	viability	and	increase	MMP	production	to	breakdown	damaged	ECM	and	allow	the	resident	cells	to	lay	down	new	ECM	(Santos	et	al.,	2013;	Sun	et	al.,	2013).	On	the	other	hand,	pro-inflammatory	cytokines	produced	as	a	response	 to	 IVD	damage	can	 trigger	an	exaggerated	 inflammatory	 response	 leading	 to	 IVD	 degeneration	 (Figure	 4)	(Antoniou	et	al.,	1996;	Gabr	et	al.,	2011;	Hoyland	et	al.,	2008;	Moreth	et	al.,	2012;	Rutges	et	al.,	2008;	Seguin	et	al.,	2005;	Smith,	Nerurkar,	et	al.,	2011;	Sun	et	al.,	2013;	Zhao	 et	 al.,	 2007).	 IL-1	 has	 been	 found	 to	 be	 much	 more	 prevalent	 in	 IVDs	undergoing	degeneration,	particularly	in	NP	region	of	the	IVD	(Hoyland	et	al.,	2008).	Furthermore,	 high	 levels	 of	 IL-1	 appear	 to	 affect	 cell	 morphology	 and	 ECM	composition,	increasing	the	proportion	of	chondrocyte-like	cells	that	are	less	adept	at	producing	new	collagen	fibres,	and	reducing	the	amount	of	aggrecan	in	the	NP.	As	previously	 discussed,	 the	 reduction	 of	 proteoglycans	 in	 the	 NP	 reduces	 the	 IVD’s	ability	 to	maintain	 hydrostatic	 pressure	 and	 increases	 the	 risk	 of	 degeneration	 to	the	IVD	(Hoyland	et	al.,	2008).	Similar	trends	were	found	when	the	IVD	was	exposed	to	TNF-α	for	prolonged	periods	of	time.	TNF-α	caused	down	regulation	of	aggrecan,	
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type	I	collagen,	and	type	II	collagen	and	the	upregulation	of	IL-1	and	IL-6	(Iatridis	et	al.,	2009).																
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Figure	4.	The	Two	Faces	of	Inflammation	In	a	controlled	inflammatory	response	we	hypothesize	that	inflammation	will	stiffen	the	 IVD,	 which	 will	 have	 a	 stabilizing	 effect	 on	 the	 IVD	 and	 promote	 healing.	However	 in	 many	 cases	 inflammation	 become	 exaggerated,	 inducing	 further	 IVD	degeneration	 and	 increased	 IVD	 laxity.	 	 This	 in	 turn	 will	 promote	 abnormal	movement	 of	 the	 IVD,	 inducing	 further	 IVD	 degeneration	 exacerbating	 a	 cycle	 of	damage.		
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1.7.	The	Rat	Tail	Model		 The	rat-tail	model	has	become	a	particularly	popular	method	for	examining	the	genetic	factors,	altered	mechanics,	and	effects	of	injury	on	IVD	integrity	(Chan	et	al.,	2006;	Masuda	et	al.,	2005;	O’Connell	et	al.,	2007;	Sobajima	et	al.,	2005;	Zhao	et	al.,	2007).	The	rat-tail	model	proves	to	be	a	cost	effective	method	for	researching	the	IVD,	with	animals	reaching	full	skeletal	maturity	by	about	3	months.	This	means	the	time	 frame	needed	 to	propagate	animals	and	conduct	 studies	 can	be	done	shortly	after	 animals	 reach	 skeletal	 maturity.	 In	 contrast,	 other	 larger	 species,	 such	 as	bovine,	while	possibly	having	more	comparable	 IVDs	 in	size	and	morphology,	also	carry	 significantly	 more	 costs	 and	 larger	 time	 expenditures	 needed	 to	 perform	comparable	 experiments.	 Relatedly,	 IVDs	 in	 the	 rat	 tail	 are	 easily	 accessible;	reducing	 the	 chance	 of	 complications	 or	 contamination	when	harvesting	 the	 IVDs	for	 tissue	 collection.	 Location	 of	 the	 IVD	 also	 allows	 treatments	 to	 be	 minimally	invasive	and	results	are	more	reproducible	compared	to	other	models	(Ching	et	al.,	2003;	H.	Zhang	et	al.,	2011;	Iatridis	et	al.,	1999;	MacLean	et	al.,	2003).		Despite	these	factors,	which	make	the	rat	tail	model	suitable	for	this	IVD	study,	there	are	several	drawbacks	that	must	be	examined.	First,	there	is	obvious	size	variance	between	rats	and	 humans.	 The	 cellular	 composition	 between	 human	 and	 rat	 IVDs	 also	 shows	some	variances,	namely	the	prevalence	of	notochord	cells	in	the	NP.	Where	humans	lose	the	majority	of	their	notochord-like	cells	by	about	3	months,	the	NP	cells	of	the	rat	 IVD	maintain	 their	 notochord	 like	morphology	 (Ching	 et	 al.,	 2003;	 Han	 et	 al.,	2008;	 Iatridis	 et	 al.,	 1999).	 Finally	 we	 must	 consider	 the	 way	 the	 IVD	 is	 loaded	
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during	daily	 activity	between	 the	 two	models.	Unlike	with	human	 IVDs	where	we	see	the	majority	of	loading	on	the	IVD	being	applied	in	the	cranial-	caudal	direction	with	 forces	 being	 dissipated	 in	 the	 perpendicular	 plane,	 the	 rat	 tail	 undergoes	similar	level	loading	through	the	tendons	that	run	the	length	of	the	tail	(Rigby	et	al.,	1959).	
1.8	Biomechanical	Properties	of	the	IVD			The	IVD	undergoes	complex	interactions	between	the	AF	and	NP	allowing	the	IVD	to	withstand	 dramatically	 variable	 forces,	 and	 to	 readily	 respond	 when	 loaded	 in	 6	degrees	of	 freedom	(Palepu	et	al.,	2012).	Due	 to	 its	 structural	 complexity,	 the	 IVD	exhibits	 primarily	 anisotropic	 (altered	 mechanical	 properties	 when	 loaded	 in	different	directions)	properties.	This	is	critical	given	that	any	abnormal	distribution	of	forces	may	lead	to	increased	degeneration	and	reduced	mobility	of	the	joint.			
1.8.1	Tension,	Compression,	and	the	Neutral	Zone		Tension	 is	 defined	 as	when	 a	 structure	 is	 pulled	 apart	 or	more	 specifically	when	forces	act	on	the	same	plane	of	motion	but	in	opposite	directions	(Haiqing	&	King,	1996).	In	the	case	of	the	IVD,	the	AF	undergoes	deformation	when	tensile	forces	are	applied	allowing	 the	 IVD	to	maintain	hydrostatic	pressure	 in	 the	NP	and	conserve	structural	integrity	(Griffin	et	al.,	2016).			The	converse	 is	true	of	compression,	where	forces	acting	in	the	same	plane	push	 the	 tissue	 together	 (Haiqing	 &	 King,	 1996).	 During	 both	 standing	 and	movement,	 the	 IVD	regularly	undergoes	compressive	and	tensile	 forces,	which	are	dispersed	across	 the	NP	 thanks	 to	 the	hydrostatic	pressure	maintained	within	 the	
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IVD	 (Griffin	 et	 al.,	 2016).	 Amazingly,	 hydrostatic	 pressure	 in	 the	 IVD	 has	 been	recorded	as	being	as	much	as	50%	higher	than	the	applied	loads	(Galante,	1967).	In	both	compression	and	tension,	the	IVD	has	a	region	of	elasticity	such	that	it	is	able	to	 recover	 from	the	resulting	strain	of	an	applied	 load	without	causing	damage	 to	the	tissue	once	the	load	has	been	removed.		The	neutral	zone	(NZ)	is	the	term	given	to	define	the	range	of	motion	where	the	 least	 amount	 of	 tissue	 resistance	 is	 experienced	 and	 is	 depicted	 as	 the	 most	horizontally	 linear	 region	 of	 a	 compression-tension	 or	 force-displacement	 curve	(Figure	5)	(Smit	et	al.,	2011).	As	such,	it	is	often	used	as	a	determination	of	a	tissue’s	range	of	motion	and	as	an	 indication	of	 tissue	 laxity	or	 stiffness.	Lower	NZ	slopes	suggest	increased	laxity	while	higher	slopes	indicate	greater	stiffness.		In	 the	 case	 of	 IVDs	 a	 balance	 must	 be	 reached	 between	 having	 sufficient	laxity	when	 forces	 are	 applied	 to	 the	 IVD	 to	 allow	 for	 the	movement,	 and	enough	stiffness	 to	maintain	 the	 IVDs	 structural	 integrity,	 particularly	when	 compressive	forces	are	applied.	While	an	increase	in	stiffness	may	be	an	indicator	of	swelling	and	inflammation	 and	 promotion	 of	 a	 stabilizing	 environment	 for	 damaged	 IVDs,	increases	 in	 laxity	 in	 normal	 healthy	 IVDs	 could	 indicate	 IVD	degeneration	 as	 the	IVD	loses	its	ability	to	withstand	the	forces	applied	to	the	IVD.						
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Figure	5:	Representative	force	displacement	curve	A	 graph	 depicting	 the	 sigmoidal	 force	 displacement	 curve,	 which	 is	 used	 to	determine	 the	 neutral	 zone	 (NZ)	 size	 and	 stiffness	 of	 each	 functional	 spine	 unit	(FSU).	 Here	we	 see	 the	 amount	 of	 force	 (Y	 axis)	 the	 tissue	 undergoes	when	 it	 is	stretched	or	 compressed	 (X	 axis).	 The	NZ	 can	be	 viewed	as	 the	most	horizontally	area	 of	 the	 graph	 where	 large	 changes	 in	 displacement	 have	 little	 effect	 on	 the	forces	 exhibited	 on	 the	 IVD.	 Outside	 this	 region,	 small	 changes	 in	 displacement	deliver	large	changes	in	force.														
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1.8.3	Mechanical	Properties	of	the	Rat	Tail	IVD		 Many	 studies	 have	 been	 done	 comparing	 the	 biomechanical	 properties	between	rat	and	human	IVDs.	Upon	 initial	examination	by	Elliott	&	Sarver	(2004),	rat	 IVDs	 placed	 through	 20	 cycles	 of	 cyclic	 compression	 and	 tension	 showed	variances	in	NZ	when	compared	to	human	IVDs.	Normalizing	the	data	to	account	for	size	 differences	 between	 the	 two	 groups	 indicated	 there	 were	 no	 significant	variances	 between	 compression	 and	 torsional	 stiffness	 in	 rat	 IVDs	 compared	 to	humans	 (Elliott	 &	 Sarver,	 2004).	 This	 further	 supports	 the	 rat-tail	 model	 as	 a	suitable	alternative	 for	human	 IVD	research	despite	 there	being	differences	at	 the	cellular	level	between	the	two	species.			 In	two	additional	studies	on	the	effects	of	cyclic	loading,	rat	IVDs	were	found	to	have	stiffening	analogous	to	that	found	in	human	degenerative	IVD	studies.	IVDs	that	 were	 exposed	 to	 compressive	 loads	 had	 a	 35%	 decrease	 in	 IVD	 height	 and	increased	 stiffness	 (Iatridis	 et	 al.,	 1999).	 Corroborating	 this	 data,	 rat	 IVDs	 that	underwent	 prolonged	 cyclic	 compressive	 loading	 over	 a	 two-week	 period	experienced	increasing	levels	of	stiffness	as	time	progressed	(Ching	et	al.,	2003).			
1.8.4	Effects	of	Inflammation	on	IVD	Biomechanics			 As	previously	discussed	the	exact	role	of	 inflammation	on	the	IVD	is	mostly	uncharacterized,	 indeed,	 the	 exact	 role	 the	 inflammatory	 response	 plays	 in	 IVD	repair,	 IVD	 degeneration	 and	 general	 IVD	 mechanics	 has	 yet	 to	 be	 fully	charecterized.		
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TNF-α,	being	one	of	the	master	regulatory	factors	in	innate	immunity,	makes	it	 a	 prime	 target	 cytokine	 for	 immunity	 studies	 and	 potential	 downstream	neutralization	to	reduce	the	degenerative	effects	of	inflammation.	Along	with	being	known	 to	 influence	 IVD	 matrix	 degradation	 (Hoyland	 et	 al.,	 2008;	 Seguin	 et	 al.,	2005),	TNF-α	has	also	been	shown	to	 trigger	Wnt-β-catenin	signaling	pathways	to	inhibit	NP	cell	growth	and	proliferation	(Hiyama	et	al.,	2013).		One	study	found	explored	the	effects	of	TNF-α	on	IVD	mechanical	properties.	Regrettably	 this	 study	was	 conducted	 in	 bovine	 IVDs	 and	 thus	 any	 results	would	need	 to	 be	 further	 validated	 to	 determine	 their	 comparability	 to	 rat	 and	 human	studies,	 however	 as	 one	 of	 the	 only	 studies	 investigating	 inflammation	 and	 its	effects	on	IVD	biomechanics	it	is	a	significant	piece	of	literature.	The	study	reported	that	the	type	of	loading	the	IVD	was	exposed	to	affected	TNF-α’s	ability	to	penetrate	the	 IVD.	TNF-α	 treated	 IVDs	under	dynamic	 loading	saw	TNF-α	penetration	of	 the	IVD	in	as	little	as	8	hours	whilst	IVDs	that	underwent	static	loading	showed	no	TNF-α	penetration	during	 the	24	hour	 test	 period.	 Interestingly	TNF-α	 expression	was	highest	 in	 the	NP	of	 IVDs	that	were	subjected	to	dynamic	 loading	with	an	average	increase	of	38%,	 though	TNF-α	 levels	 in	 the	AF,	and	vertebral	endplates	were	not	significantly	different	from	controls.	Presence	of	inflammatory	cytokines	in	the	IVD	was	 also	 reported	 to	 have	 severe	 implications	 on	 IVD	 integrity	 and	 in	 all	 cases	reduced	 IVD	 compliance.	 Also,	 histological	 analysis	 showed	 increased	 collagen	production	in	the	AF	of	TNF-α	exposed	IVDs	along	with	reduced	levels	of	aggrecan	in	 the	 NP	 of	 the	 same	 IVDs	 (Walter	 et	 al.,	 2015).	 As	 aggrecan	 is	 one	 of	 the	 core	proteoglycans	of	the	NP	ECM	required	to	maintain	hydrostatic	integrity	of	the	IVD,	it	
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is	not	surprising	that	IVDs	that	experienced	loss	of	proteoglycans	also	had	severely	compromised	structural	integrity.	
1.9	Project	Aims		This	 project	 aims	 to	 analyze	 the	 effects	 on	 an	 innate	 inflammatory	 response	 on	resident	 IVD	cells	comparable	 to	what	would	be	seen	during	herniation	or	similar	IVD	damage,	 then	determine	 if	 that	 inflammatory	 response	had	any	effects	on	 the	biomechanical	properties	of	the	IVD	at	the	tissue	level.		My	 project	 can	 be	 subdivided	 into	 five	 parts	 in	 order	 to	 answer	my	 thesis	question;	the	first	part	was	to	isolate	cells	from	the	AF	and	NP	of	Sprague	Dawley	rat	(Rattus	norvegicus)	IVDs	harvested	from	the	tail	and	grow	them	in	culture;	secondly,	I	 confirmed	 the	 identity	 of	 the	 cultured	 AF	 and	 NP	 cells	 using	 RT-PCR;	 thirdly	 I	determined	 the	 basal	 expression	 levels	 of	 each	 type	 of	 innate	 PRR	 for	 both	 cell	types;	 fourthly	 I	 challenged	 the	 AF	 and	 NP	 cells	 with	 danger-	 and	 pathogen-	associated	molecular	patterns	 (DAMPs,	PAMPs)	 and	determined	 the	 inflammatory	response	 by	 measuring	 changes	 in	 cytokine	 production	 using	 a	 multiplex	 array.	Finally,	 I	 treated	 functional	 spine	 units	 (FSU)	with	 an	 inflammatory	 stimulus	 and	measure	 the	 changes	 in	 the	 biomechanical	 properties	 of	 the	 IVD	 compared	 to	untreated	controls.	I	hypothesized	that	cells	challenged	with	an	inflammatory	stimulus	will	initiate	an	inflammatory	state	by	increasing	inflammatory	cytokine	production.	This	inflammatory	response	will	lead	to	swelling	on	the	IVD	and	lead	to	an	overall	stiffening	effect	on	the	joint.	
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Chapter	2.		Materials	and	Methods	
2.3.1.	Cell	Culture		 The	 isolation	 protocol	 for	 AF	 and	 NP	 cells	 was	 adapted	 from	 cell	 culture	methods	described	previously	(Gruber	et	al.,	2002;	Hiyama	et	al.,	2013;	Kong	et	al.,	2014).	 Young	 animals	were	used	 for	 IVD	 collection	 as	 rats	 aged	2-3	months	 yield	IVD	 tissue	 with	 successful	 long-term	 annulus	 cultures	 60%	 of	 the	 time.	 Older	animals	 (8-10	months)	yield	 successful	 long-term	cultures	only	~20%	of	 the	 time	(Gruber	&	Hanley,	2014).	Seven	rats	were	used	for	AF	and	NP	cell	culturing.	AF	and	NP	 tissues	 were	 collected	 from	 the	 intervertebral	 IVDs	 of	 the	 tails	 of	 freshly	sacrificed	male	Sprague	Dawley	rats,	Rattus	Norvegicus,	under	aseptic	conditions.	All	AF	tissues	from	a	single	animal	were	pooled,	as	were	the	NP	tissues.	Tissues	were	washed	 3	 times	 in	 Dulbecco	 phosphate	 buffered	 saline	 (DPBS)	 modified	 without	calcium	 or	 magnesium	 (SH30028.02,	 HyClone,	 South	 Logan,	 UT,	 USA)	 with	 2%	penicillin-streptomycin	 stock	 (Stock	 concentration;	 200	 μl/mL	 penicillin,	 200	units/mL	streptomycin,	Fisher,	Fairlawn,	NJ,	USA).	
2.3.2.	AF	Cells		 AF	tissues	were	blunt	dissected,	using	forceps,	into	1mm2	pieces,	then	plated	in	100mm	cell	 culture	petri	dish	with	DMEM	modified	with	sodium	pyruvate,	 and	4.5	GM/L	glucose	(Bioshop,	Burlington,	Ont,	Canada),	10%	fetal	bovine	serum	(FBS,	Sigma-Aldrich,	St.	Louis,	MO,	USA),	100	μl/mL	penicillin	–	100IU/	mL	streptomycin	(1%	Pen-Strep,	Fischer,	Fairlawn,	NJ,	USA),	and	25mM	of	HEPES	free	acid	(Amresco,	Solon,	OH,	USA).	
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Tissues	were	initially	cultured	in	2mL	of	media	until	pieces	of	tissue	had	adhered	to	the	petri	dish,	then	the	media	volume	was	gradually	increased	to	10mL	with	50%	of	media	being	changed	3	 times/	week	until	 tissue	explant	growth	had	occurred	and	cells	had	 reached	confluence.	Cells	were	 incubated	at	37oC	with	5%	supplemental	CO2	throughout	the	culturing	process.	Once	cells	has	reached	confluence,	they	were	subcultured	1:2	in	vented	T75	flasks,	after	cells	had	been	washed	2	times	with	DPBS	with	2%	Pen-Strep	then	lifted	with	2mL	of	0.25%	trypsin/	0.53mM	EDTA	(30-2101,	ATCC,	Manassas,	VA,	USA).	
2.3.3.	NP	Cells		 NP	 tissues	 were	 broken	 up	 by	 vigorously	 pipetting	 then	 plated	 in	 poly-L-lysine	 coated	 T75	 vented	 flasks	 with	 RPMI-1640	 (30-2001,	 ATCC,	 Manassas,	 VA,	USA)	supplemented	with	10%	FBS,	1%	pen-strep	and	25mM	HEPES.	NP	cells	were	incubated	and	subcultured	as	previously	described	in	2.3.2.	
2.3.4.	NR8383	–	Rat	Lung	Macrophage	Cells		 NR8383	 cells	 were	 purchased	 from	 ATCC	 (CRL-2192,	 Cedarlane	 labs,	Burlington,	Ont,	Canada)	and	plated	at	4x105	cells/mL	 in	T75	vented	 flasks	as	per	manufacturer’s	instructions	in	Ham’s	F12K	media	with	15%	FBS	and	1%	pen-strep.	Cells	were	 incubated	 at	 37oC	with	 5%	 supplemental	 CO2	throughout	 the	 culturing	process	and	subcultured	1:2	by	detaching	the	cells	using	a	cell	scraper.	As	with	the	other	cell	types	50%	of	the	media	was	changed	3	times	per	week	to	maximize	cell	growth.	
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2.3.5	RT-PCR	AF,	 NP	 and	 NR8383	 RNA	 were	 collected	 from	 cell	 cultures	 using	 Sigma’s	GeneElute	Mammalian	 Total	 RNA	Miniprep	Kit	 (Sigma-Aldrich,	 St	 Louis,	Missouri,	USA,	Catalogue	#RTN70-1KT)	 following	manufacturer’s	 instructions	 (Appendix	B).	All	 3-cell	 types	 were	 run	 against	 the	 primers	 listed	 in	 Table	 1	 to	 generate	 PRR	expression	 profiles	 using	 the	 NR8383	 cells	 as	 positive	 controls	 for	 all	 primers.	Primers	 were	 purchased	 from	 Sigma-Aldrich	 (St.	 Louis,	 MO,	 USA).	 Annealing	temperature	 for	 each	 primer	 pair	was	 optimized	 in	 a	 previous	 PCR	 reaction,	 and	then	the	optimum	temperature	was	used	 in	this	 final	set	of	RT-PCR	reactions.	The	control	lane	is	an	RT-PCR	reaction	using	the	GAPDH	primers	but	substituting	cDNA	for	DNA	quality	water	 to	 ensure	no	 contaminants	 are	 present.	 	 	 RT-PCR	products	were	 ran	 on	 a	 1%	 agarose	 gel	 stained	 with	 0.5	 μg/mL	 EtBr.	 Images	 taken	 on	 a	VersaDoc	 4000	 with	 UV	 trans	 illuminator,	 1.4	 F-stop	 fixed	 lens	 and	 5-second	exposure.	 	 The	 identity	 of	 each	 RT-PCR	 product	 was	 validated	 via	 sequencing	(Laboratory	Services	Division,	University	of	Guelph,	Guelph,	Ont,	Canada).									
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Table	1.	RT-PCR	Primers	Complete	 list	 of	 primers	 used	 to	 identify	 PRRs	 expression	 in	 the	 AF	 and	 NP	 cell	cultures	using	RT-PCR.	Also	listed	are	primer	used	to	verify	cell	identity	as	AF	or	NP.	Included	are	the	forward	and	reverse	primer	sequences,	the	expected	product	size	of	each	PCR	product,	and	the	cognate	ligand	for	each	receptor.		
Target	 Associated	Ligands	 Forward	Primer	 Reverse	Primer	 Product	Size	
Annealing	
Temp	
TLR1	 Short	Leucine	Rich	
Proteoglycans	
(SLRPs)	
5'-GCTATGGCAGTGGACACAGA-3'	 5'-CCAGAACTCCCCAGTGTTGTT-3'	 601	 55oC	
TLR2	 5’-ATGAGTCCCGAAGTCTACAGTCA-3’	 5’-GCTCCGTATTGTTACCGTTTCTAC-3’	 383 50oC 
TLR3	 dsRNA	 5ʹ-GATTGGCAAGTTATTCGTC-3ʹ	 5ʹ-GCGGAGGCTGTTGTAGG-3ʹ	 205	 50oC	
TLR4	
Short	Leucine	Rich	
Proteoglycans	
(SLRPs)/LPS	
5’-CGCTCTGGCATCATCTTCAT-3’	 5’-CTCCTCAGGTCAAAGTTGTTGC-3’	 232	 55oC	
TLR5	 Host	RNA	 5ʹ-GAATCCGGAACCTAGCGCAT-3ʹ	 5ʹ-GCACCCTGTTGACACGAAAA-3ʹ	 664	 50oC	
TLR6	 Bacterial	
Lipoproteins	
5ʹ-GGGGCTTTCCTCTGTCTCTA-3ʹ	 5ʹ-CCCAAGTTTCAAGTTTTCACAT-3ʹ	 593	 55oC	
TLR7	 Host	RNA	
Host	RNA	
5ʹ-GTCACCTCTATTTCTGGGATGT-3ʹ	 5ʹ-AATCACATCAACTTTTTCATCC-3ʹ	 379	 50oC	
TLR8	 5'-CGGAAAGGGGAAAACATGTCC-3'	 5'-TTTGGGTGCTGTTGTTTGGC-3'	 317	 50oC	
TLR9	 Host	DNA	 5’-CATCATGGTTCTCTGTAGCAGG-3’	 5’-AGCAGTTCCCGTCCATGAAG-3’	 539	 50oC	
TLR10	 Unknown	 5ʹ-TTTTCCAGAGCTGCCAGGAG-3ʹ	 5ʹ-GGGTCAAAGTTCCTCTCGGG-3ʹ	 502	 55oC	
RIG-I	
Host	RNA	
5'-TGACTGCTTCCGTTGGTGTT-3'	 5'-CAAAGCCTTCAAACCTCCGC-3'	 558	 50oC	
MDA5	 5'-AGCACAGACTTGGATAACGCA-3'	 5'-TGCACACCATCATCTTCCCC-3'	 689	 50oC	
NLRP3	
Short	Leucine	Rich	
Proteoglycans	
(SLRPs)	
5'-TGCATGCCGTATCTGGTTGT-3'	 5'-TGCATCATTCCACTCTGGCT-3'	 686	 55oC	
DAI	
Host	DNA	
5'-CCCAGAGTCAACCACCACTG-3'	 5'-CTCCATTGCTTTCTGGCCTCA-3'	 415	 50oC	
AIM2	 5'-GGTGTTTTCCAGGCTGATCC-3'	 5'-AGGTGGCAGAAGCAACAGAA-3'	 390	 55oC	
MINCLE	 Host	Proteins	 5'-TGCATCACACCACACAGAGAG-3'	 5'-GATAACCACCAGGTGAGCCC-3'	 337	 55oC	
DECTIN	 Necrotic	Cells	 5'-AGGCATCCCAAACTACAGGC-3'	 5'-TGACTTGAAACGAGTTGGGGG-3'	 300	 55oC	
GAPDH	 None	 5'-GCATCTTCTTGTGCAGTGCC-3'	 5'-ACTGTGGTCATGAGCCCTTC-3'	 567	 55oC	
COMP	 None	 5'-CCACTGCCTGCGTTCTAGT-3'	 5'-AAGCATCTGTGGGGCTAGGT-3'	 95	 55oC	
GLY3	 None	 5'-GCCCTGAACCTCGGAATTGA-3'	 5'-AGCAGTACCACATTCGGGTG-3'	 94	 55oC	
K19	 None	 5'-TGATGAGACGTTGAACACCCA-3'	 5'-CGAGTTCCGTGACCTCAGTC-3'	 97	 55oC							
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2.3.6.	Multiplex	Assay	AF	cells	(passage	<4)	were	plated	in	12	well	plates	and	were	allowed	to	grow	in	a	monolayer	in	regular	growth	media	previously	described.	NP	cells	(passage	<4)	were	similarly	plated	in	poly-L-lysine	coated	12	well	plates.	Wells	were	treated	with	media	 alone	 or	 with	 10	 μg/mL	 LPS	 (Sigma-Aldrich,	 Oakville,	 Ont,	 Canada),	 or	 5	μg/mL	bovine	decorin	(Sigma-Aldrich,	Oakville,	Ont,	Canada,	Cat#D8428),	 for	each	time	point	or	2,	6,	12,	18,	22	and	24	hours.	Concentration	of	LPS	and	Decorin	were	chosen	 based	 on	 previous	 studies	 (Schaefer	 et	 al.,	 2005b)	 with	 concentrations	chosen	that	induced	noticeable	changes	in	inflammatory	cytokine	production.	Cells	were	 exposed	 to	 serum	 free	 conditions	 for	 the	 initial	 2	 hours	 then	 media	 was	changed	 to	 normal	 growth	 media	 for	 each	 cell	 type	 with	 the	 above-mentioned	agonist	 concentrations	 for	 the	 duration	 of	 the	 experiment.	 Serum	 free	media	was	initially	 used	 as	 FBS	 was	 seen	 to	 have	 a	 protective	 effect	 on	 the	 cells	 delaying	inflammatory	cytokine	production.	All	media	was	collected,	 centrifuged	at	15.0x	G	for	15	minutes	before	being	aliquoted	into	60	μl	aliquots	and	stored	at			-80	oC	until	multiplex	assays	were	performed.	Multiplex	 reagent	 kits	 were	 purchased	 from	 Bio-Rad	 (Bio-Rad,	 Mississauga,	 Ont,	Canada)	along	with	Rat	standards	and	cytokine	for	TNF-α,	MIP-2,	RANTES,	IL-6,	and	MCP-1.	Multiplex	assays	were	performed	according	 to	manufacturer’s	 instructions	using	a	Bio-Plex	MAGPIX	Multiplex	Reader	(Bio-Rad,	Mississauga,	Ont,	Canada).				
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2.3.7	Biomechanical	Testing		 19	male	 Sprague	Dawley	 rats,	 averaging	1	 year	 old	 and	550g-650g,	 (rattus	
norvegicus)	were	obtained	 from	the	Wilfrid	Laurier	University	Animal	Care	Center	(Waterloo,	 Ont,	 Canada),	 which	 were	 being	 kept	 under	 other	 faculty	 member’s	existing	 approved	 animal	 utilization	 protocols.	 Freshly	 sacrificed	 animals	 were	dissected	 and	 3	 FSUs	 were	 collected	 from	 each	 animal	 tail.	 FSUs	 were	 randomly	assigned	 to	 the	 test	 conditions	outlined	 in	Table	2.	 FSUs	exposed	 to	decorin	were	injected	 with	 20ul	 of	 PBS	 solution	 with	 the	 prescribed	 dissolved	 decorin	concentrations	(0.5	or	5	μg/mL)	whilst	PBS	only	samples	were	injected	with	20uL	of	PBS	(Figure	6).	Injections	were	carried	out	using	a	33	gauge	needle,	placed	in	2mLs	of	normal	DMEM	growth	media	and	incubated	at	37	oC.	Following	incubation	of	24	hours	 or	 6	 days,	 FSUs	were	mechanically	 tested	 using	 a	 uniaxial	material	 testing	system	(UStretch,	CellScale	Biomaterials	Testing,	Waterloo,	Ont,	Canada)	(Figure	7).	FSUs	were	subjected	to	10	cycles	of	cyclic	compression	and	tension	to	precondition	the	IVD	and	determine	the	loading	limits	of	the	IVD.	IVDs	were	further	subjected	to	an	additional	15	cycles	of	compression	and	tension	using	the	last	cycle	to	generate	a	force	displacement	curve	(Figure	5).	Biomechanical	data	was	collected	and	analyzed	using	MatLab	software	 to	graph	 the	 force-displacement	curve	 for	each	FSU	and	 to	determine	the	NZ	size	and	stiffness.			
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Table	2.	Experimental	Conditions	for	Biomechanical	Testing	A	table	illustrating	the	experimental	conditions	and	how	each	FSU	was	divided	between	the	9	test	conditions.	3	FSUs	were	harvested	from	each	rat	with	each	FSU	randomly	assigned	to	1	of	the	3	treatment	groups.		
Test	Condition	 Treatment	1	 Treatment	2	 Treatment	3	1	Day	Incubation	(N=8)	 5	μg/mL	Decorin	 0.5	μg/mL	Decorin	 PBS	6	Days	Incubation	(N=8)	 5	μg/mL	Decorin	 0.5	μg/mL	Decorin	 PBS								
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Figure	6:	FSU	Harvesting	and	Experimental	Setup		A	diagram	depicting	the	3	FSUs	being	harvested	which	were	randomly	assigned	to	the	3	experimental	groups;	untreated	control,	sham	(PBS)	injection,	20	uL	injection	of	0.5	μg/mL	decorin	solution,	or	20	uL	injection	of	5.0	μg/mL	decorin	solution.	
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Figure	7:	UStretch	used	for	compression-tension	testing		Image	 depicting	 the	 UStretch	 (Cellscale,	 Waterloo,	 Ont,	 Canada)	 used	 for	compression-tension	testing	of	all	FSUs	from	each	of	the		test	conditions	(0.5	μg/mL	Decorin	in	PBS;	5	μg/mL	Decorin	in	PBS;	PBS	only)																
FSU	
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2.3.8	Statistics			Statistical	 analysis	 of	 multiplex	 data	 (cytokine	 and	 chemokine	 raw	 concentration	values)	was	performed	using	SAS	V9.2	(SAS	Institute	Inc.,	Toronto,	Ont.,	Canada)	via	a	two-way	ANOVA	with	the	factors	“condition”	(three	levels:	control,	LPS,	decorin)	and	 “time	 point”	 (six	 levels:	 2,	 6,	 12,	 18,	 22,	 24hrs).	 Tukey’s	 post-hoc	 tests	 were	conducted	to	determine	significant	changes	 in	cytokine/chemokine	concentrations	for	 each	 condition	 and	 time	 point	 as	 well	 as	 on	 fold	 changes	 in	 LPS	 and	 decorin	cytokine/chemokine	concentrations	relative	to	control	at	each	individual	time	point.	A	second	two-way	ANOVA	was	conducted	on	the	NZ	size	and	stiffness	data	with	the	factors	 “incubation	period”	 (two	 levels:	24	hrs	and	6	days)	and	 “condition”	 (three	levels:	0.5	μg/mL	decorin,	5.0	μg/mL	decorin,	PBS	control).	P<0.05	was	considered	to	be	significant.			
Chapter	3.	Results	
2.4.1	Cell	Culture		 Over	 the	 course	 of	 this	 experiment,	 AF	 and	 NP	 tissues	 were	 successfully	isolated	and	primary	cell	cultures	were	established	(Figure	8).	AF	cells	were	visibly	sandwiched	 as	 round	 cells	 between	 layers	 of	 collagen	 fibers.	 In	 addition	 to	 being	larger	 than	 their	 NP	 counterparts,	 AF	 cells	 appeared	 to	 have	 a	 fibroblastic	morphology	 in	 culture.	 Five	 days	 post-culture,	 the	 first	 AF	 cells	 were	 visible	migrating	 away	 from	 the	 explant	 tissues.	 Cell	 populations	 quickly	 expanded	 such	that	within	10	days	post-culturing	the	AF	cells	had	reached	confluence	in	T75	flasks.	
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NP	cells	similarly	had	a	round	morphology	upon	initial	culturing.	Cells	could	be	seen	attached	to	the	poly	–	L	–	lysine	coated	flasks	within	24	hours	of	culturing.	Despite	this,	 it	 took	 10	 days	 for	 cells	 to	 take	 on	 their	 final	morphology	 and	 begin	 visible	growth.	Cells	took	an	additional	5-10	days	to	reach	confluence	in	a	T75.	Cell	 identity	 and	 purity	 of	 primary	 cell	 cultures	was	 confirmed	 using	 RT-PCR.	 AF	cells	showed	high	expression	of	cartilage	oligomeric	matrix	protein	(COMP)	but	no	expression	 of	 glypican	 3	 (GLY3)	 or	 cytokeratin	 19	 (K19).	 Conversely,	 NP	 cells	showed	 no	 expression	 of	 COMP,	 though	 GLY3	 and	 K19	 were	 both	 present.	 	 As	expected	 both	 the	 AF	 and	 NP	 cells	 show	 strong	 expression	 of	 our	 control	 gene,	GAPDH	(Figure	9).													
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Figure	8:	Culturing	AF	and	NP	Cells		Images	 depicting	 the	 growth	 of	 cultured	 AF	 and	NP	 cells.	 Both	 cell	 types	 initially	have	 a	 rounded	morphology	 with	 NP	 cells	 being	 free	 floating	 and	 AF	 cells	 being	trapped	 between	 collagen	 fibres.	 Once	 cells	 attach	 or	 being	 to	 explant	 their	morphology	changes.	AF	cells	were	noted	 to	reach	confluence	around	day	15	post	culture	whilst	NP	cells	took	an	additional	10	days.																				
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Figure	9:	Confirmation	of	AF	and	NP	cell	identity		RT-PCR	 results	 of	 cartilage	 oligomeric	 matrix	 protein	 (COMP),	 glypican	 3	 (Gly3),	cytokeratin	 19	 (K19)	 transcript	 expression	 in	 AF	 and	NP	 cells,	 using	 GAPDH	 as	 a	housekeeping	control	gene.	AF	cells	expressed	COMP	and	GAPDH	whilst,	Gly3,	K19	and	 GAPDH	 were	 all	 expressed	 by	 NP	 cells.	 Differential	 expression	 by	 our	 two	primary	cell	 cultures	allowed	 for	verification	of	cell	 identity	between	 the	different	cell	populations.																														
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2.4.2	PRR	Expression	Profiles		 PRR	 expression	 profiles	 were	 generated	 using	 NR8383	 cells	 as	 positive	controls.	 NR8383	 cells	 expressed	 a	 wide	 range	 of	 receptors	 showing	 positive	expression	for	all	PRRs	tested	along	with	our	control	gene,	GAPDH	(Figure	10).	AF	and	NP	cells	showed	varied	expression	between	the	two	cell	types.	AF	cells	showed	strong	expression	of	TLR	2,	3,	4,	and	6	as	well	as	RIG-I.	Expression	of	TLR	1,	7,	8,	and	9,	 MDA5,	 Mincle,	 and	 Dectin	 were	 also	 present	 though	 at	 much	 weaker	 levels	(Figure	11	–	AF).	NP	cells	showed	much	stronger	expression	of	TLR	1,	2,	3,	4,	6,	and	Dectin,	though	TLR	5,	8,	9;	RIG-I	and	AIM2	were	also	present	(Figure	11	–	NP).	PRR	expression	profiles	were	also	noted	to	be	consistent	between	primary	cell	cultures	obtained	 from	 non-familial	 animals	 where	 PRR	 profiles	 generated	 from	 3	individuals	from	different	litters	were	all	found	to	have	the	same	PRR	profiles.						
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Figure	10:	NR8383	PRR	expression	profile		Expression	profile	of	PRRs	expressed	rat	 lung	macrophage	cell	 line	as	detected	by	RT-PCR,	using	primers	from	Table	1.	GAPDH	was	used	as	a	positive	control.	Each	set	of	 primers	 yielded	products	 of	 the	 correct	 size,	which	were	 subsequently	 verified	via	sequencing.								
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Figure	11:	AF	and	NP	PRR	Expression	Profiles		Representative	expression	profiles	of	PRRs	at	the	transcript	level	in	AF	cell	cultures	(AF)	and	NP	cell	cultures	(NP)	using	RT-PCR	(N=3).		Each	primer	annealing	temperature	was	optimized	in	previous	PCR	reactions	then	the	optimum	temperature	was	used	in	this	final	set	of	RT-PCR	reactions.	The	control	used	GAPDH	primer	 but	 substituted	 cDNA	 for	DNA	 quality	water	 to	 ensure	 there	were	no	contaminates	to	the	PCR	mixtures.			 						
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2.4.3	Cytokine	Expression		 As	 TLR2	 and	 TLR4	were	 visibly	 expressed	 in	 both	 cell	 types,	 a	 PAMP	 and	DAMP	 for	 these	 receptors,	 LPS	 and	 decorin	 respectively,	were	 selected	 for	 use	 in	challenge	 studies.	 AF	 cells	 challenged	 with	 LPS	 showed	 early	 peak	 expression	 of	MCP-2	 and	 MIP-2,	 with	 expression	 peaking	 at	 57.68	 and	 38.35	 fold	 greater	 than	untreated	 controls	 respectively,	 (6	 hours	 post	 exposure)	 before	 expression	 levels	began	 returning	 to	 normal	 levels.	 Expression	 was	 not	 found	 to	 be	 statistically	different	 between	 6	 hours	 and	 24	 hours	 post	 treatment.	 Production	 of	 IL-6	 and	RANTES	were	 found	 to	 peak	 at	 18	 hours	 (137.93	 and	 161.08	 times	 greater	 than	controls)	with	expression	quickly	dropping	by	22	hours	(Figure	12a).	Production	of	RANTES	was	 not	 statistically	 different	 between	 12	 hour	 and	 18	 hour	 time	 points	whilst	 IL-6	 was	 not	 statistically	 variable	 between	 18	 and	 22	 hours,	 though	 was	found	to	have	significant	variance	between	12	and	18	hour	time	points.	In	NP	cells,	IL-6	followed	a	similar	trend,	though	in	much	greater	concentrations,	to	that	of	AF	cells	treated	with	LPS.	Peak	levels	of	the	cytokine	were	385.57	times	greater	at	18	hours	 then	 controls.	 RANTES	 and	 MIP-2	 showed	 delayed	 increases	 in	 cytokine	production,	not	peaking	until	22	hours	(74.87	and	61.6	fold	increase;	18,	22,	and	24	hour	 time	points	were	not	 significantly	different	 from	each	other	 for	RANTES;	12,	18,	22,	and	24	hour	time	points	were	not	significantly	different	from	each	other	for	MIP-2)	 and	 had	 not	 shown	 significant	 reduction	 in	 cytokine	 production	 at	 the	conclusion	 of	 the	 experiment	 (Figure	 12b).	 In	 contrast	 to	what	was	 seen	with	AF	cells,	 NP	 cells	 showed	 no	 significant	 changes	 in	 MCP-1	 expression	 compared	 to	control	 levels	at	any	point	during	 the	 time	course	 (Figure	12).	AF	cells	 challenged	
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with	 decorin	 showed	 similar	 expression	 profiles	 to	 that	 of	 their	 LPS	 challenged	counterparts.	Expression	levels	were	noted	to	be	lower	in	all	cases	when	cells	were	challenged	with	decorin	compared	to	cells	challenged	with	LPS	(IL-6	=	95.91,	MCP-1	=	 43.37,	RANTES	=	 98.62,	MIP-2	=	 30.67).	MCP-1	 and	MIP-2	both	peaked	 earliest	whilst	 RANTES	 again	 peaked	 at	 18	 hours.	 IL-6	 expression	 also	 showed	 a	 delayed	response	when	 challenged	with	 decorin,	 and	 did	 not	 peak	 until	 22	 hours	 (Figure	13a).	Surprisingly	NP	cells	treated	with	decorin	did	not	show	the	same	expression	profiles	 to	 LPS	 treated	 cells,	 loosing	 expression	 of	 RANTES	 in	 addition	 to	 MCP-1	(Figure	13b).	 IL-6	however,	did	peak	at	18	hours	again	as	was	observed	when	NP	cell	were	treated	with	LPS	but	the	PAMP	induced	a	4	times	stronger	reaction	than	the	decorin	treated	cells.	MIP-2	was	also	noted	to	peak	earlier	than	LPS	treated	cells	at	 12	 hours	 (62.34	 fold	 great	 than	 controls).	 Neither	 cells	 treated	 with	 LPS	 or	decorin	showed	increases	in	TNF-	α	production	from	control	values.		
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Figure	12:	Cytokine	Expression	Following	LPS	Stimulation	in	AF	and	NP	Cells		
Figure	12:	Multiplex	data	over	a	24-hour	time	course	showing	the	fold	change	in	IL-6,	MCP-1,	RANTES,	and	MIP-2	expression	in	AF	cells	(A)	and	NP	cells	(B)	treated	with	10	μg/mL	LPS	relative	to	control.	N=3.	Asterisks	indicate	significant	fold	change	from	control	at	each	individual	time	point.	Statistics	reported	are	based	on	raw	data	values	(*	p<0.05,	**p<0.005,	***p<0.0005,	****p<0.00005).			
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Figure	13:	Cytokine	Expression	Following	Decorin	Stimulation	in	AF	and	NP	Cells		Multiplex	data	over	a	24-hour	time	course	showing	the	fold	change	in	IL-6,	MCP-1,	RANTES,	and	MIP-2	expressions	in	AF	cells	(A)	and	NP	cells	(B)	treated	with	5	μg/mL	Decorin	relative	to	control.	N=3.	Asterisks	indicate	significant	fold	change	from	control	at	each	individual	time	point.	Statistics	reported	are	based	on	raw	data	values	(*	p<0.05,	**p<0.005,	***p<0.0005,	****p<0.00005).		
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2.4.4	Effects	of	Incubation	Time	and	Inflammation	on	IVD	Biomechanical	Properties		 NZ	size	was	not	affected	by	either	the	length	of	incubation	(24	hours	versus	6	days;	 p=0.1612)	 nor	 by	 the	 addition	 of	 decorin	 (p=0.3727).	 However	 collapsed	across	 condition	 (0.55	 μg/mL	 decorin,	 5.0	 μg/mL	 decorin,	 and	 PBS),	 NZ	 stiffness	was	 lower	 after	 6	 days	 of	 culture	 when	 compared	 to	 24	 hours	 (p=0.0377).	Moreover,	 a	 significant	 interaction	 between	 incubation	 time	 and	 the	 addition	 of	decorin	was	observed	 for	NZ	stiffness	 (p=0.0329).	 	This	 interaction	was	 such	 that	decorin,	 regardless	 of	 concentration,	 0.5	 μg/mL	 or	 5.0	 μg/mL,	 had	 no	 significant	effect	 on	 IVD	 NZ	 stiffness	 (p=0.40)	 following	 24	 hours	 of	 incubation	 (Figure	 14)	when	 compared	 to	 the	PBS	 control	 samples	but	did	have	an	effect	 after	6	days	of	incubation.	 Specifically,	 increased	 NZ	 compliance	 was	 observed	 in	 5.0	 μg/mL	decorin	samples	compared	to	PBS	control	samples	(p=0.016)	and	close	to	significant	increased	compliance	in	the	0.5	μg/mL	decorin	samples	(p=0.09).										
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Figure	14:	Neutral	Zone	Stiffness	Over	Time		Graph	depicting	significant	interaction	between	incubation	time	(24	hours	versus	6	days)	and	condition	(PBS,	0.5	μg/mL	decorin,	and	0.5	μg/mL	decorin)	for	NZ	stiffness	(p=0.0329).	NZ	stiffness	did	not	differ	between	conditions	after	24	hours	incubation	(p=0.40);	however	by	6	days,	decorin	injected	samples	showed	increased	laxity	(p=0.09	and	p=0.016,	for	0.5	ug/mL	and	5	μg/mL	decorin	injected	IVDs	respectively)	when	compared	to	the	sham	IVDs	at	6	days,	as	indicated	by	the	asterisk.	Further,	the	NZ	stiffness	for	the	sham	IVDs	did	not	change	from	24	hours	to	6	days.	
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Chapter	4.	Discussion		The	 current	 study	utilized	 a	multi-disciplinary,	 integrative,	 and	novel	 approach	 to	investigating	inflammation	in	the	IVD.		Through	this	work	a	collaborative	approach	was	 undertaken,	with	work	 being	 conducted	 in	 both	 the	DeWitte-Orr	 lab	 and	 the	Gregory	 lab,	 but	 also	 by	 integrating	 the	 fields	 of	 biomechanics,	 immunology	 and	cellular	 biology.	This	 has	 allowed	us	 to	 compare	 changed	observed	 at	 the	 cellular	level	to	functional	changes	at	the	tissue	level.	A	number	of	key	findings	were	observed:	first,	it	was	found	that	both	a	PAMP	(LPS)	and	a	DAMP	(decorin)	resulted	in	a	significant	 increase	 in	pro-inflammatory	chemokine	 and	 cytokine	 production	 in	 cultured	 AF	 and	 NP	 cells.	 	While	 this	was	anticipated	 as	 it	 was	 also	 found	 that	 both	 IVD	 cell	 types	 have	 TLR2	 and	 TLR4	receptors	 on	 which	 LPS	 and	 decorin	 bind,	 such	 extensive	 PRR	 profiles	 and	progression	 of	 cytokine	 production	 have	 never	 been	 reported	 previously	 in	 the	literature.	 	 Second,	 intact	 IVDs,	 when	 injected	 with	 decorin,	 became	 significantly	more	 compliant	 after	 6	 days	 of	 culture,	 compared	 to	 control	 IVDs,	 indicating	 a	potentially	 negative	 effect	 of	 inflammation	 on	 IVD	 joint	mechanical	 integrity.	 This	increased	 laxity	could	have	detrimental	effects	 if	 the	 IVD	 is	exposed	to	a	 longterm	inflammatory	environment.		
4.1	Culturing	AF	and	NP	Cells	and	the	Identification	of	PRRs		The	 present	 study	 shows	 that	 the	 resident	 cells	 of	 the	 AF	 and	 NP	 can	 be	successfully	 grown	 in	 culture	 from	 tissues.	 At	 present,	 cells	 were	 successfully	cultured	 from	tissues	harvested	 from	the	 IVDs	of	rat-tails	 (Figure	8).	 In	each	case,	
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cells	had	the	expected	morphology	and	cellular	markers	previously	described	in	the	literature.	 In	 contrast,	 growth	 conditions	 required	 to	 sustain	 NP	 cell	 growth	 had	several	 variations	 to	 what	 had	 been	 previously	 described,	 namely	 changing	 the	growth	 media	 from	 DMEM	 to	 RPMI	 and	 the	 use	 of	 poly-L-lysine	 coated	 culture	flasks.	These	changes	were	made	to	enhance	cell	viability	as	we	observed	culturing	NP	 cells	 in	 DMEM	 caused	 osmotic	 variation	 leading	 to	 cell	 bloating	 in	 most,	 and	eventually	death.	Furthermore,	using	proteases	to	breakdown	of	the	NP	ECM	using	the	 isolation	 process,	 identified	 in	 the	 literature	 (Lee	 et	 al.,	 2015),	 was	 also	discontinued	as	this	caused	similar	cellular	bloating	and	death	observed	when	using	DMEM.	Also,	NP	cells	were	highly	susceptible	to	shearing	forces,	particularly	in	the	initial	passages.	Additionally,	establishing	successful	primary	cell	cultures	was	also	dependent	on	the	age	of	the	animal	from	which	the	tissues	were	harvested.	Animals	between	3	and	6	months	had	the	most	success	when	establishing	cultures	and	also	had	 the	most	 rapid	 growth	 of	 NP	 cells.	 AF	 cells	 in	 contrast	 appeared	 to	 be	much	more	 robust	 and	 grew	 remarkably	 well	 under	 established	 conditions.	 AF	 cells	collected	 from	both	young	and	old	animals	 could	be	successfully	explanted	within	the	time	frames	established	in	figure	8.			Additionally,	 the	cell	 identity	of	each	primary	culture	was	confirmed	based	on	the	unique	cellular	makers	expressed	by	each	cell	 type.	The	protein	COMP	was	found	to	be	uniquely	expressed	by	AF	cells	but	not	by	NP	cells	whilst.	Conversely,	GLY3	 and	 K19	 is	 predominantly	 produced	 by	 NP	 cells	 when	 compared	 to	 rat	 AF	tissue	and	articular	cartilage	(	Lee	et	al.,	2007).		
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From	those	pure	cell	cultures	we	have	determined	the	PRR	profiles	for	each	of	our	cell	 types	and	have	 identified	PRRs	 common	 to	both	AF	and	NP	cells,	which	were	chosen	 for	challenge	studies.	PRR	expression	was	measured	at	 the	 transcript	 level	using	RT-PCR	and	it	was	determined	that	AF	and	NP	cells	expressed	different	PRR	profiles	(Figure	11).	While	the	variation	in	PRR	profiles	was	expected,	the	exact	list	of	receptors	expressed	by	each	cell	should	help	fill	a	critical	gap	in	the	literature	and	as	such	help	determine	future	possible	areas	of	study	for	IVD	related	inflammation.	The	 fact	 that	 TLRs	 2	 and	 4	 were	 both	 expressed	 by	 the	 AF	 and	 NPs	 became	 a	particularly	interesting	avenue	to	explore	as	these	PRRs	suited	many	of	our	criteria	making	them	excellent	potential	targets	for	this	experiment.	Some	of	these	criteria	included	 the	 PRRs	 having	well	 characterized	 inflammatory	 pathways	with	 known	cytokine	 production	 giving	 us	 viable	 targets	 to	 characterize	 for	 inflammatory	profiles	using	the	multiplex	array.	The	PRRs	having	known	DAMP	and	PAMP	stimuli	was	also	an	asset	as	it	allowed	us	to	compare	and	contrast	inflammatory	responses	with	 different	 origins	 Furthermore,	 being	 expressed	 on	 the	 surface	 of	 the	 cell	removed	the	need	to	internalize	are	stimuli	of	choice	and	any	neutralizing	antibody	which	may	be	used	in	future	studies	for	blocking	assays.	
4.2	Challenging	AF	and	NP	cells	with	DAMP/PAMP		AF	 and	 NP	 cells	 were	 then	 exposed	 to	 a	 DAMP,	 (decorin),	 and	 the	 PAMP,	(LPS),	 to	 determine	 the	 inflammatory	 profiles	 of	 5	 chosen	 pro-inflammatory	cytokines	 over	 a	 24-hour	 time	 course.	 Cytokines	 were	 chosen	 based	 on	 several	factors.	 Previous	 literature	 where	 TNF-α	 was	 used	 to	 determine	 the	 effects	 of	
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inflammation	 on	 IVDs	 (Walter	 et	 al.,	 2015)	 and	 the	 fact	 TNF-α	 is	 considered	 a	master	 regulator	 of	 innate	 immunity	 contributing	 to	 vasodilation	 related	 immune	cell	 recruitment	made	 it	 an	 	 excellent	 candidate	 for	 this	 study.	 IL-6	 has	 similarly	been	 characterized	 in	 the	 literature	 to	 play	 a	 role	 in	 IVD	 degeneration	 via	 MMP	mediated	 ECM	 degradation	 (Burke	 et	 al.,	 2002;	 Deng	 et	 al.,	 2016).	 The	immunoprivileged	 nature	 of	 the	 IVD	 also	 means	 that	 it	 will	 require	 the	 help	 of	external	 immune	 cells.	We	hypothesized	 resident	 cells	 of	 the	 IVD	will	 take	on	 the	role	as	 sentinels	 for	damage	and	 infection	 then	 recruit	 specialized	 innate	 immune	cells.	 Three	 chemokines;	 MIP-2,	 RANTES,	 and	 MCP-1,	 were	 thus	 also	 chosen	 as	cytokine	candidates	as	together	these	three	chemokines	are	capable	of	recruiting	a	wide	variety	of	specialized	innate	immune	cells.		Progression	of	 the	 inflammatory	 response	 for	 each	 cytokine	based	 location	within	 the	 IVD	 allows	 us	 to	 build	 an	 idea	 of	 what	 cells	 are	 bing	 signaled	 for	 the	different	 DAMP/PAMP	 response	 (Table	 3).	 LPS	 induced	 inflammation	 in	 AF	 cells	showed	early	peak	expression	of	MCP-1	and	MIP-2,	which	was,	sustained	though	the	24	 hour	 time	 course.	 This	 suggests	 early	 recruitment	 of	 macrophages	 and	leukocytes.	 This	 response	 is	 similar	 to	 what	 could	 be	 expected	 in	 a	 bacterial	infection	where	a	strong	immediate	immune	response,	capable	of	clearing	invading	pathogens	and	not	ceasing	until	the	infection	has	been	removed,	is	preferable.	Late	stage	IL-6	production	may	support	this	hypothesis	given	the	pathogen	could	not	be	removed	and	the	next	phase	of	inflammation	is	starting	(initiation	of	fever	inducing	cytokines).	 Similar	 supporting	 evidence	 can	 be	 seen	 in	 the	 AF	 and	NP	 data	when	cells	 were	 treated	 with	 damage	 associated	 ligands.	 The	 generally	 lower	 levels	 of	
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cytokine	 production	would	 produce	 a	weaker	 immune	 response,	 and	may	 be	 the	IVDs	method	to	creating	a	more	balanced	inflammatory	response	that	will	promote	healing.	 	The	NP	cells	 inability	 to	produce	MCP-1	and	thus	recruit	monocytes	may	also	 be	 a	 factor	 of	 geography.	 As	 the	 most	 internal	 region	 of	 the	 IVD	 it	 may	 be	preferential	to	have	the	AF	and	VEP	act	as	sentinels	for	damage	and	infection.	Being	more	closely	located	to	tissues	and	blood	vessels	where	macrophages	reside	the	AF	will	be	far	more	efficient	at	recruiting	them	when	a	PAMP	or	DAMP	is	sensed.	Once	inflammation	 was	 confirmed	 in	 both	 cell	 types	 the	 scope	 of	 the	 experiment	 was	increased	to	establish	if	the	inflammatory	response	presented	by	the	cells	had	any	effect	 on	 the	 biomechanical	 properties	 of	 the	 IVD	 when	 a	 decorin-induced	inflammatory	response	was	initiated.													
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Table	3:	Summary	of	Cytokines	and	their	Possible	Biological	Effects	A	summary	of	the	production	of	each	cytokine	the	possible	effect	of	resulting	from	cytokine	 production	 and	 its	 proposed	 implications	 in	 the	 context	 of	 the	 immune	response.			 IL-6	 MCP-1	 RANTES	 MIP-2	
Role	 Induces	fever,	increases	MMP	production	 Recruitment	of	monocytes	 Recruitments	of	T-cells,	eosinophils	and	basophils	
Recruitment	of	leukocytes	
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4.3	The	Effect	of	Induced	Inflammation	on	IVD	Biomechanics		 This	 study	 examined	 the	 role	 of	 inflammation	 on	 IVD	 biomechanics	 by	separating	 the	 physical	 damage	 to	 the	 IVD	 from	 the	 inflammatory	 response	 by	injecting	the	IVDs	directly	with	the	DAMP,	decorin.	Specifically	a	small	gauge	needle	was	used	to	minimize	damage	to	the	IVD	in	order	to	isolate	any	changes	caused	by	the	addition	of	decorin	rather	than	damage.	In	this	study,	an	inflammatory	response	was	 induced	 in	 the	 IVD	 when	 injected	 with	 decorin.	 This	 led	 to	 increased	 laxity	(Figure14)	 6	 days	 post	 -injection,	 particularly	 with	 the	 higher	 concentration	 of	decorin	 (5	 μg/mL),	 potentially	 as	 a	 result	 of	 ECM	 degradation.	 When	 an	inflammatory	response	is	controlled,	inflammation	may	aid	in	IVD	regeneration	and	repair	by	improving	cell	viability	and	increasing	extracellular	matrix	production	and	rearrangement	to	promote	healing	(Rastogi	et	al.,	2013;	Santos	et	al.,	2013;	Sun	et	al.,	2013).	However	the	inflammatory	process	can	easily	become	unbalanced.		Increases	 in	 IL-6	 and	MMP	 production	 have	 been	 shown	 to	 alter	 the	 ECM	composition	 (Deng	 et	 al.,	 2016).	 A	 heightened	 inflammatory	 response	 in	 concert	with	the	avascular	nature	of	the	IVD	would	lead	to	increased	ECM	breakdown	along	with	 less	nutrients,	 oxygen	availability,	 and	 clearance	of	 cellular	waste.	 Instead	of	repair	 to	 the	 IVD	 via	 MMP	 mediated	 ECM	 restructuring,	 the	 lack	 of	 resources	delivered	to	the	IVD	would	fail	 to	meet	the	 increased	cellular	demands	needed	for	increased	 cell	 growth	 and	 the	 laying	 of	 new	 ECM.	 This	 would	 cause	 further	degeneration	of	the	IVD	and	increased	IVD	laxity	as	a	result.	Interestingly,	increased	laxity	 following	 exposure	 to	 innate	 cytokines	 is	 contrary	 to	 what	 has	 been	previously	noted	in	the	literature.	Specifically,	bovine	IVDs	challenged	with	TNF-	α	
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resulted	in	a	stiffening	effect	(Walter	et	al.,	2015)	rather	than	increased	compliance.	This	 could	 be	 due	 to	 several	 factors	 that	 include	 a	 variation	 in	 IVD	 responses	between	 rat	 and	bovine	 IVDs,	 or	 in	 the	manner	 in	which	 the	 IVD	ECM	 is	 affected.	Walter	et	al.	specifically	noted	the	increase	in	collagen	production	and	the	reduction	in	 aggrecan	 in	 the	NP.	 Since	 there	was	no	 significant	 change	 in	TNF-α	production	during	the	decorin	or	LPS	induced	inflammatory	response,	 it	stands	to	reason	that	the	 lack	 of	 TNF-α	 and	 upregulation	 of	 other	 inflammatory	 cytokines	 caused	 a	different	 response	 in	 the	 IVD	 that	 that	 seen	 by	Walter	 et	 al.	 leading	 to	 increased	laxity.	This	is	possible	because	the	lack	of	TNF-α	production	may	not	have	increased	collagen	 production	 in	 our	 model	 as	 was	 seen	 in	 the	 bovine	 IVDs.	 Instead,	degradation	of	collagen	fibers	and	other	ECM	components	caused	by	increased	MMP	due	to	higher	levels	of	IL-6	activity	could	account	for	the	increased	laxity	observed	in	 our	 study.	 To	 confirm	 this	 hypothesis	 histology	 would	 be	 needed	 showing	changes	of	collagen	concentrations	in	decorin	treated	rat	IVDs.	
Future	Directions		Further	 experimentation	 to	 determine	 if	 the	 identified	 inflammatory	response	 can	 be	mitigated	 is	 still	 needed;	 however,	we	 hypothesize	 the	 following	based	on	our	results.	Native	molecules	in	the	ECM	of	the	IVD,	such	as	decorin,	would	become	solubilized	during	IVD	herniation.	These	DAMPs	are	sensed	by	resident	AF	and	NP	cells	via	their	PRRs,	such	as	TLR2	and	4	(Figure	15-1),	which	in	turn	would	produce	 pro-inflammatory	 cytokines	 and	 chemokines	 (Figure	 15-2).	Macrophages	in	the	tissues	surrounding	the	IVD	and	neighbouring	blood	vessels	would	follow	the	
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chemokine	 gradient	 to	 the	 site	 of	 herniation	 (Figure	 15-3).	 Once	 at	 the	 site	 of	herniation,	the	macrophages	would	begin	to	produce	different	cytokines	(IL-1β	and	TNF-α)	at	high	levels	to	aid	on	IVD	remodeling	and	repair	(Figure	15-4).	Conversely,	these	cytokines	would	also	induce	resident	AF	cells	to	secrete	proteases	that	cause	ECM	 degradation,	 which	 over	 time	 would	 lead	 to	 IVD	 laxity	 and	 degeneration	(Rastogi	 et	 al.,	 2013).	 It	 has	 been	 shown	 that	 AF-secreted	 proteases	 break	 down	proteoglycans	 like	 decorin	 (Rutges	 et	 al.,	 2008),	which	would	 result	 in	 a	 reduced	ability	 for	 the	NP	to	retain	water	and	an	 increased	activation	of	resident	cells	and	recruited	macrophages	by	 their	TLR	2	and	4	pathways,	producing	more	cytokines	and	a	positive	feedback	loop.	 	These	two	effects	in	turn	could	alter	the	hydrostatic	equilibrium	 and	 mechanical	 integrity	 of	 the	 IVD,	 leading	 to	 direct	 effects	 on	 the	IVD’s	biomechanics	(Han	et	al.,	2008;	Issy	et	al.,	2013;	Michalek	et	al.,	2010).	Loss	of	hydrostatic	 pressure	 in	 the	 NP	 would	 reduce	 the	 IVD’s	 ability	 to	 displace	compressive	 forces,	 which	 would	 be	 exerted	 along	 the	 rest	 of	 the	 spine	 as	 a	consequence.	Protease-mediated	structural	changes	in	the	AF	would	further	reduce	the	 IVD’s	 ability	 to	withstand	 compressive	 forces	during	movement.	This	 could	 in	turn	 cause	 further	 fissures	 within	 the	 IVD	 increasing	 the	 probability	 for	 new	herniations	to	occur	(Inoue	&	Espinoza	Orias,	2011;	Gregory	et	al.,	2012;	Michalek	et	al.,	2010).			As	 several	 treatments	 have	 been	 developed	 to	 target	 and	 suppress	 the	activity	of	IL-6	and	TNF-α,	all	of	which	are	meeting	variable	clinical	success	(Molinos	et	al.,	2015),	this	further	highlights	the	complexity	of	the	innate	immune	system	and	its	role	 in	LBP.	Currently,	studies	using	neutralizing	drugs	to	target	TNF-	α	or	IL-6	
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have	shown	mixed	results	 in	clinical	trials	(Risbud	&	Shapiro,	2014;	Molinos	et	al.,	2015).	These	results	may	be	explained	by	the	fact	that	 inflammation	is	affected	by	the	cumulative	actions	of	multiple	cytokines	working	in	cohort.	Therefore	targeting	any	 individual	 cytokine	 will	 have	 limited	 results.	 Instead	 blocking	 of	 the	 PRR	pathway	 with	 neutralizing	 antibodies	 or	 inhibitors	 would	 block	 inflammation	upstream	of	cytokine	production	mediating	all	inflammatory	cytokines	produced	as	a	consequence	of	PRR	activation,	instead	of	just	a	single	end	product.	This	could,	in	turn,	 increase	 the	 efficiency	 of	 reducing	 inflammation	 and	 preventing	 further	 IVD	degeneration	following	herniation.	Based	on	this	work	I	hope	that	further	research	will	be	undertaken	to	investigate	the	effectiveness	of	treatment	protocols	that	target	upstream	 receptors	 to	 help	 alleviate	 the	 inflammatory	 response	 before	 it	 reaches	the	 degenerative	 stage	 currently	 being	 seen	 in	 IVDs	 (Figure	 16).	We	 believe	 that	targeting	upstream	PRRs	that	initiate	the	inflammatory	response	could	prove	to	be	a	highly	effect	treatment	strategy.										
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Figure	15:	Proposed	progression	of	a	decorin	mediated	inflammatory	response	(1)	Herniation	occurs	causing	bound	decorin	in	the	extracellular	matrix	of	IVDs	to	become	solubilized.	Solubilized	decorin	binds	to	surface	PRRs	such	as	TLR	2	and	4	of	resident	AF	and	NP	cells	within	the	IVD.	(2)	PRR	activation	causes	a	signal	cascade	(Figure	3)	resulting	in	the	release	of	pro-inflammatory	cytokines	and	chemokines.	(3)	These	released	chemokines	form	a	concentration	gradient	recruiting	specialized	innate	immune	cells	like	macrophages	from	the	surrounding	tissue	and	blood	vessels	to	the	site	of	herniation.	(4)	The	macrophages	begin	releasing	their	own	cytokines	such	as	TNF-	α	promoting	further	inflammation	and	activating	an	adaptive	immune	response.	This	culminates	to	pain	and	further	IVD	degeneration.			
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Figure	16:	Proposed	Model	for	Limiting	Inflammatory	Progression	We	hypothesis	that	using	a	neutralizing	antibody	that	targets	PRRs	and	blocks	them	from	 initiating	 an	 inflammatory	 response	we	will	 be	 able	 to	 reduce	 inflammation	and	in	turn	the	degradative	effects	seen	within	IVDs.	We	hope	that	this	will	provide	a	novel	avenue	for	future	therapeutics.	
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Summary		 1. The	main	subject:	LBP	and	innate	immunity	a. LBP	is	a	highly	prevalent	condition	across	the	world	with	 limited	treatment	 options.	 Lack	 of	 treatments	 lead	 to	 LBP	 being	 a	significant	 drain	 on	medical	 resources.	 LBP	 is	 likely	 initiated	 by	damage-triggered	 innate	 immune	 responses	by	 the	 resident	 cells	of	 the	 IVD,	 however	 this	 is	 not	 well	 understood,	 nor	 how	 this	innate	 immune	 response	 affects	 IVD	 biomechanics.	 This	 projects	looks	to	integrate	both	cellular	and	biomechanical	components	to	better	understand	this	phenomenon.		2. Main	findings:	a. Pure	AF	 and	NP	 cells	 can	 be	 successfully	 cultured,	 in	 vitro,	 from	the	rat	tail.	b. AF	and	NP	cells	have	similar	but	unique	PRR	expression	profiles	c. Both	 AF	 and	 NP	 cells	 respond	 to	 PAMPs	 and	 DAMPs	 specific	 to	TLR2/4,	namely	LPS	and	decorin	respectively.	d. When	stimulated	with	LPS	and	decorin,	AF	and	NP	cells	produce	cytokines	and	chemokines	AF	and	NP	cells	consistently		produced	increased	levels	of	IL-6	and	MIP-2.	AF	cells	also	produced	RANTES	and	 MCP-1,	 though	 RANTES	 upregulation	 in	 NP	 cells	 was	stimulant	dependent.	NP	cells	also	did	not	upregulate	MIP-2,	and		TNF-α	levels	were	not	upregulated	in	either	cell	type.	
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e. Decorin	caused	increased	laxity	in	IVD	biomechanics	at	6d	but	not	24h	 post	 exposure,	 suggesting	 resident	 cell	 inflammation	 causes	IVD	ECM	degradation.	3. Implications	of	findings:	a. Blocking	TLR2/4	signaling	may	be	a	viable	therapeutic	strategy	for	treating	LBP	by	reducing	inflammation	at	its	source.	
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5.	Appendices	
Appendix	A	–	Primary	Cell	Culture		
F-12K	Growth	Media	(For	NR8383	Cells)		This	will	yield	500mLs	of	F-12K	growth	media	with	15%	FBS,	1%	Penicillin-Streptomycin	and	25mM	HEPEs			You	Will	Need:	1. 1x500mL	bottle	of	F-12K	media	(Kaighn’s	modification	of	Ham’s	F-12	growth	media	supplemented	with	2mM	L-glutamine	and	1500mg/L	sodium	bicarbonate	(ATCC,	Purchased	through	Cedarlane,	Burlington	Ont.	Canada,	Catalogue	#	30-2004)		2. 75mL	of	Heat	Inactivated	Fetal	Bovine	Serum	(FBS)	(Sigma-Aldrich,	St.Louis,	Missouri,	USA,	Catalogue	#	F6178)		 3. 5mLs	of	100U/mL	Penicillin	/100	μg/mL	Streptomycin	Antibiotics	(Fisher	Scientific,	Fiarlawn,	NJ,	USA)		 4. 12.5mLs	of	1M	sterile	filtered	HEPEs	free	acid	(pH	7.4)			In	aseptic	conditions	remove	87.5mls	of	F-12K	media	and	store	in	50ml	falcon	tubes	at	4oC	for	later	use.		Add	75mLs	of	FBS,	5mLs	of	Pen-Strep	solution	and	12.5mLs	of	1M	HEPEs.		Mix	and	store	at	4oC	until	needed.												
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DMEM	Growth	Media	(For	AF	Cells)		This	will	yield	500mLs	of	DMEM	growth	media	with	10%	FBS,	1%	Penicillin-Streptomycin	and	25mM	HEPEs			You	Will	Need:	1. 1x500mL	bottle	of	Dulbecco’s	Modified	Eagle	Medium	(DMEM)	(ATCC,	Purchased	through	Cedarlane,	Burlington	Ont.	Canada,	Catalogue	#	30-2002)		2. 50mL	of	Fetal	Bovine	Serum	(FBS)	(Sigma-Aldrich,	St.Louis,	Missouri,	USA,	Catalogue	#	F6178)		 3. 5mLs	of	100U/mL	Penicillin	/100	μg/mL	Streptomycin	Antibiotics	(Fisher	Scientific,	Fiarlawn,	NJ,	USA)		 4. 12.5mLs	of	1M	sterile	filtered	HEPES	free	acid	(pH	7.4)			In	aseptic	conditions	remove	62.5mls	of	DMEM	media	and	store	in	50ml	falcon	tubes	at	4oC	for	later	use.		Add	50mLs	of	FBS,	5mLs	of	Pen-Strep	solution	and	12.5mLs	of	1M	HEPEs.		Mix	and	store	at	4oC	until	needed.																						
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RPMI	Growth	Media	(For	NP	Cells)		This	will	yield	500mLs	of	RPMI	growth	media	with	10%	FBS,	1%	Penicillin-Streptomycin	and	25mM	HEPEs			You	Will	Need:	1. 1x500mL	bottle	of	RPMI	Medium	1640	(Gibco,	Fisher	Scientific,	Fairlawn,	NJ,	USA,	Catalogue	#	A10491-01)	with:	-	
• 4.5g/L	D-Glucose	
• 2.383	g/L	HEPES	Buffer	
• L-Glutamine	
• 1.5g/L	Sodium	Bicarbonate	
• 110mg/L	Sodium	Pyruvate		2. 50mL	of	Fetal	Bovine	Serum	(FBS)	(Sigma-Aldrich,	St.Louis,	Missouri,	USA,	Catalogue	#	F6178)		 3. 5mLs	of	100U/mL	Penicillin	/100	μg/mL	Streptomycin	Antibiotics	(Fisher	Scientific,	Fiarlawn,	NJ,	USA)				In	aseptic	conditions	remove	50mls	of	RPMI	media	and	store	in	a	50ml	falcon	tube	at	4oC	for	later	use.		Add	50mLs	of	FBS	and	5mLs	of	Pen-Strep	solution.		Mix	and	store	at	4oC	until	needed.				
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Appendix	B	–	PCR		
B1.	RNA	Extraction	RNA	extraction	was	performed	from	cell	culture	using	the	Sigma	GeneElute	Mammalian	Total	RNA	Miniprep	Kit	(Sigma-Aldrich,	St	Louis,	Missouri,	USA,	Catalogue	#RTN70-1KT)		Cells	were	detached	using	standard	Trypsin-EDTA	and	pelleted	before	being	processed	using	the	RNA	kit.		
Preparation	Instructions	
	Before	beginning	the	procedure,	prepare	the	following:		
1.	Prepare	the	Lysis	Solution/2-ME	Mixture		Add	2-mercaptoethanol	(2-ME)	(M3148)	to	a	volume	of	Lysis	Solution	(L8285)	sufficient	for	that	day’s	use,	usually	500	μL	of	Lysis	Solution/2-ME	Mixture	per	RNA	preparation.	2-ME	is	required	to	fully	inactivate	RNases.	Add	10	μL	of	2-ME	for	each	1	mL	of	Lysis	Solution.		
2.	Dilute	Wash	Solution	2	Concentrate	
	Dilute	the	Wash	Solution	2	Concentrate	(W3261)	with	10	mL	(10	prep	package),	60	mL	(70	prep	package),	or	300	mL	(350	prep	package)	of	200	proof	ethanol	(E7023).	After	each	use,	tightly	cap	the	diluted	Wash	Solution	2	to	prevent	evaporation	of	the	ethanol.		
Procedure		All	steps	are	carried	out	at	room	temperature	except	where	otherwise	noted.	Please	note	that	centrifugation	speeds	are	given	in	units	of	g.	Convert	to	rpm	depending	on	size	of	centrifuge	rotor,	according	to	the	formula:		RCF	=	1.118	×	10-5	×	radius	(in	cm)	×	rpm2	where	RCF	=	gravitational	acceleration	in	units	of	g.	If	centrifuges/rotors	for	the	required	g-forces	are	not	available,	use	the	maximum	g-force	possible	and	increase	the	spin	time	proportionally.	Spin	until	all	liquid	passes	through	column.		
A.	Cell	Preparation		For	best	yields	of	intact	RNA	use	only	rapidly	growing	cells	before	they	reach	their	maximum	density.			
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1a.	Harvest	Cells		•	Suspension	cell	cultures:	Pellet	up	to	1	×107	cells	for	5	minutes	at	300	×	g.	Remove	the	culture	medium	completely	and	discard.	Continue	with	step	2a.	•	Attached	cell	cultures:	Attached	cells	can	be	lysed	directly	in	culture	vessels	or	released	with	trypsin	and	pelleted	before	lysis.	To	lyse	cells	directly,	remove	culture	medium	completely,	then	continue	with	step	2a.	Alternatively,	trypsinize	and	pellet	cells	using	standard	methods	and	proceed	as	for	suspension	cultures.		
2a.	Lyse	cells	and	inactivate	RNase	
	This	is	a	critical	step	that	must	be	accomplished	quickly	and	thoroughly.	The	resulting	lysate	may	be	stored	at	–70	°C	for	several	months.		•	Pelleted	cells:	Vortex	pellet	to	loosen	cells.	Add	250	μL	of	the	Lysis	Solution/2-ME	Mixture	for	up	to	5	×	106	cells	or	500	μL	of	the	Lysis	Solution/2-ME	Mixture	for	5	×	106	to	1	×	107	cells.	Vortex	or	pipette	thoroughly	until	all	clumps	disappear.	Continue	with	step	3a.	
3a.	Filter	lysate	This	step	removes	cellular	debris	and	shears	DNA,	and	may	be	omitted	with	fewer	than	106	cultured	cells.	Assemble	a	filtration	column	(CP9346)	with	a	2	mL	collection	tube	(T5449).	Carefully	pipette	the	lysed	cells	from	step	2a	onto	the		filtration	column.	Centrifuge	at	maximum	speed	(12,000–16,000	×	g)	for	2	minutes.	Discard	the	filtration	column.		
4a.	Prepare	for	binding	
	Add	an	equal	volume	of	70%	ethanol	solution	(500	μL)	to	the	filtered	lysate.	Vortex	or	pipette	thoroughly	to	mix.	Continue	to	Section	D.		
D.	RNA	Isolation	This	is	a	continuation	of	the	procedure	from	the	samples	prepared	in	Sections	A		
1d.	Load	lysate	into	binding	column	
	Assemble	a	binding	column	(CP9471)	with	a	2	mL	collection	tube	(T5449).	Pipette	700	uL	of	the	lysate/	ethanol	mixture	from	step	4a,	4b	or	6c	onto	the	binding	column.	If	the	volume	of	lysate/ethanol	mixture	is	greater	than	700	μL,	the	RNA	must	be	bound	to	the	column	in	2	steps.	Centrifuge	at	maximum	speed	for	15	seconds.	Discard	the		flow-through	liquid,	but	retain	the	collection	tube.	Return	the	binding	column	to	the	collection	tube	and	apply	any	remaining	lysate/ethanol	mixture	to	the	column.	Repeat	the	centrifugation	as	described	above.	Discard	the		flow-through	liquid,	but	retain	the	collection	tube.		
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2d.	On	Column	DNase	I	Digestion		1.	Pipette	250	μL	of	Wash	Solution	1	into	the	column	and	centrifuge	at	maximum	speed	for	15	seconds.	2.	Mix	10	μL	of	DNase	I	(D2816)	with	70	μL	of	DNase	Digest	Buffer	(D1566)	for	each	preparation.	Mix	by	inversion.	Do	not	vortex	the	DNase	I	or	the	DNase	I/Digest	Buffer	mixture.	DNase	I	is	sensitive	to	physical	denaturation.	3.	Add	80	μL	of	the	DNase	I/Digest	Buffer	mixture	directly	onto	the	center	of	the	Binding	Column.	5.	Incubate	at	room	temperature	for	15	minutes.	6.	Pipette	250	μL	of	Wash	Solution	1	into	the	column	and	centrifuge	at	maximum	speed	for	15	seconds.	This	is	a	critical	step.	Omission	may	result	in	20–80%	loss	of	RNA.	7.	Transfer	the	binding	column	into	a	fresh	2.0	mL	collection	tube,	and	continue	with	Section	D,	step	3.		
3d.	Second	column	wash		Transfer	the	binding	column	into	a	fresh	2	mL	collection	tube.	Discard	the		flow-through	liquid	and	the	original	collection	tube.	Ensure	that	Wash	Solution	2	Concentrate	(W3261)	has	been	diluted	with	ethanol	as	described	in	the	Preparation	Instructions.	Pipette	500	μL	of	this	ethanol	containing	Wash	Solution	2	into	the	column	and	centrifuge	at	maximum	speed	for	15	seconds.	Discard	the		flow-	through	liquid,	but	retain	the	collection	tube.		
4d.	Third	column	wash		Pipette	a	second	500	μL	volume	of	Wash	Solution	2	into	the	column	and	centrifuge	at	maximum	speed	for	2	minutes	to	dry	the	binding	column.		
Optional	spin	to	further	dry	the	column.	The	binding	column	must	be	free	of	ethanol	before	eluting	the	RNA.	Centrifuge	the	column	for	an	additional	1	minute	at	maximum	speed	if	any	residual	Wash	Solution	2	is	seen	on	the	surface	of	the	binding	column.	Empty	and	re-use	the	collection	tube	if	you	need	this	additional	centrifugation	step.			
5d.	Elute	RNA		Transfer	the	binding	column	to	a	fresh	2	mL	collection	tube.	Pipette	50	μL	of	Elution	Solution	(E8024)	into	the	binding	column	and	centrifuge	at	maximum	speed	for	1	minute.	If	greater	than	50	μg	of	RNA	is	expected	(see	Expected	Yield	under	Results),	repeat	the	elution	with	a	second	50	μL	volume	of	Elution	Solution,	collecting	both	eluates	in	the	same	tube.	Purified	RNA	is	now	in	the		flow-through	eluate	(~45	or	90	μL	total),	and	is	ready	for	immediate	use	or	storage	at	–70	°C.	Keep	the	RNA	on	ice	whenever	it	is	thawed	for	use	
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B2.	cDNA	Synthesis	–	iScript		RNA	collected	from	the	GeneElute	Mammalian	Total	RNA	MiniPrep	Kit	was	quantified	using	the	Thermo	Scientific	NanoDrop	Lite	Spectrophotometer.		 1. Put	RNA,	iScript	Reverse	Transcription	Supermix	for	RT-qPCR	(Bio-Rad	Laboratories,	Mississauga,	Ont,	Canada,	Catalogue	#1708840),	and	DNA	Quality	Water	on	ice.	2. Combine	1ug	of	RNA,	4ul	iScript	Supermix,	and	enough	DNA	quality	H2O	to	make	20ul	total	volume.	3. Place	tubes	in	thermocycler	and	use	the	iScript	protocol	listed	below			1.	25oC	for	5:00	minutes	2.	46oC	for	20:00	minutes	3.	95oC	for	1:00	minute	4.	4oC	for	∞		Keep	all	cDNA	at	4oC	until	needed	and	store	at	-20oC	if	long-term	storage	is	necessary.			Unused	RNA	should	be	stored	at	-80oC	until	required	for	cDNA	synthesis	and	freeze	thawing	should	be	avoided																						
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B3.	RT-PCR	–	GoTaq		 1. Thaw	GoTaq	Green	2x	Master	Mix	(Promega	Corporation,	Madison,	WI,	USA,	Catalogue	#	M712B)	and	RT-PCR	Primers.		2. Place	cDNA,	DNA	Quality	Water,	Primers,	and	GoTaq	Master	Mix	on	ice.	3. Mix	appropriate	volumes	of	cDNA,	water,	forward	and	reverse	primers	and	master	mix	according	to	manufacturers	specification.	4. ½	reaction	volumes	(12ul)	were	used	to	screen	PCR	products	with	larger	volumes	being	produced	and	purified	for	sequencing	purposes.	5. Samples	were	placed	in	the	thermocycler	after	PCR	contents	were	mixed	and	spun	down.	Samples	were	run	through	the	following	protocol	as	all	target	PCR	products	were	under	1kB	is	size.		 1. 95oC	–	2	minutes	2. 95oC	–	45	seconds	3. 50	-55oC	–	60	seconds	(exact	annealing	temperature	was	optimized	for	each	set	of	primers)	4. 72oC	-	1	minute		Repeat	steps	2-4	34x		5. 72oC	-	10	minutes	6. 4oC	-	∞																						
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B4.	Gel	Electrophoresis		Gels	are	prepared	based	on	the	number	of	samples	being	screened.	Generally	screening	of	PRR	profiles	was	completed	using	a	medium	sized	gel	(20	Wells)		1. Mix	together	appropriate	amounts	of	agarose	(Bio-Rad	Laboratories,	Hercules,	CA,	USA,	Catalogue	#	61-3101)	and	1xTAE	buffer	in	a	bench	pint	based	on	the	following	combinations	to	make	a	1%	agarose	gel.	If	PCR	products	are	particularly	small	<	300bp,	better	resolution	between	product	sized	can	be	obtained	by	increasing	the	agarose	concentration	from	1.5-2.0%		 .	Small	gel	(8	wells)	–	0.4g	agarose	+	40mL	1x	TAE	buffer	.	Medium	gel	(20	wells)	–	1g	agarose	+	100mL	1x	TAE	buffer	.	Large	gel	(40	wells)	–	2g	agarose	+	200mL	1x	TAE	buffer		2. Close	bottle	with	a	vented	lid	and	heat	in	microwave	mixing	every	30	seconds	until	the	agarose	completely	dissolves.	3. Pour	gel	into	a	leveled	gel	caster;	comb	out	any	bubbles	in	the	gel	using	the	gel	comb	to	rake	them	to	the	bottom	of	the	gel.	Place	comb	in	the	groove	slots.	4. Allow	gel	to	fully	solidify	5. Place	gel	and	caster	in	rig	filled	with	buffer	then	remove	the	comb.	6. Turn	on	power	pack,	set	voltage	to	110	volts	and	time	to	1hr	(voltage	and	run	times	may	vary	based	on	gel	size,	product	size	and	the	level	of	resolution	between	PCR	products	required)	7. Load	samples	leaving	1	well	for	a	gene	ruler	of	your	choice	8. Let	gel	run	9. Once	gel	has	finished	running	take	gel	and	place	it	in	EtBr	stain	(0.5	μg/mL	EtBr	in	MilliQ	water)	for	10	minutes.	10. Destain	in	MilliQ	water	for	a	minimum	of	20	minutes	11. Image	gel	under	camera	capable	of	UV	trans	illumination	such	as	a	Bio-Rad	Versa	doc.	or	other	suitable	imager.	Exact	exposure	times	will	vary	depending	on	exact	equipment	specifications.											
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Appendix	C	–	Multiplex		
		
Figure	17:	Multiplex	Protocol		Multiplex	protocol	used	to	determine	the	concentration	of	several	cytokines	from	a	single	50ul	sample.	1)	Magnetic	beads	with	various	capture	antibodies	are	mixed	together	depending	on	which	cytokines	will	be	tested	for.	The	bead	mixture	are	pipetted	into	each	well	of	a	96	well	plate.	2)	The	plate	is	placed	in	a	magnetic	holder	that	holds	the	beads	in	place	then	each	well	is	washed	three	times	with	wash	buffer	to	remove	unbound	beads	from	the	wells.	3)	Serial	dilutions	are	prepared	from	stock	samples	of	each	cytokine	being	tested	and	pipetted	into	individual	wells	on	the	plate	in	duplicate.	4)	Media	samples	containing	the	cytokines	being	tested	are	also	plated	and	allowed	to	incubate	for	1hour.	The	wells	are	washed	three	times	with	wash	buffer	to	remove	unbound	sample.	5)	Biotinylated	detection	antibodies	are	added	to	each	well	and	allowed	to	incubate	for	30	minutes.	Unbound	detection	antibodies	are	washed	away	by	again	washing	each	well	three	times	with	wash	buffer.	6)	Streptavidin	is	added	to	amplify	the	signal	from	the	biotinylated	detection	antibodies.	7)	This	results	in	the	antigen	being	sandwiched	between	the	magnetic	
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bead	and	streptavidin	signal.	8)	This	complex	is	detected	and	quantified	by	comparing	the	data	from	the	standards	and	samples	allowing	us	to	determine	the	concentration	of	each	cytokine	at	various	stages	of	the	innate	immune	response	after	challenging	each	cell	line	with	different	danger	associated	molecules.		
